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ABSTRACT 
According to the working hypothesis put forth, the role of Cl- in excitation-
contraction coupling is altered in salt hypertension, in part, due to altered nitric oxide 
(NO)/NO synthase pathways. To test this hypothesis, an assessment was made of the 
hemodynamic, mechanical, electrical and morphological properties in mesenteric blood 
vessels from Dahl salt-resistant normotensive (SRN) and salt-sensitive hypertensive 
(SSH) rats. Female Dahl salt-resistant and salt-sensitive rats were placed on a 4% salt 
diet for 7 weeks. The Dahl SSH rats had significantly higher blood pressure, heart rate, 
I 
and body weight compared to SRN. In addition, the SSH rats had left ventricular and 
renal hypertrophy, but the plasma and total blood volume were not different compared to 
SRN. Morphological examination revealed an increase in media thickness and lumen 
diameter in mesenteric arteries from SSH, but the ratio of the two was not different 
between the strains. 
The a 1-adrenoceptor agonist, cirazoline, produced a dose-dependent increase in blood 
pressure, decrease in heart rate, mesenteric blood flow, and mesenteric vascular 
conductance in anesthetized SRN and SSH rats. The nitric oxide synthase inhibitor Nw 
nitro-L-arginine methyl ester (L-NAME) increased blood pressure, decreased mesenteric 
blood flow and conductance in SRN but not in SSH. Niflumic acid-induced attenuation 
of cirazoline-mediated decreases in mesenteric blood flow and conductance was more 
pronounced in SRN than in SSH rats. This difference in the inhibitory actions of niflumic 
acid was abolished by pretreatment with L-NAME. 
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In isolated perfused mesenteric blood vessels, replacement of Cl- with propionate ions 
significantly inhibited cirazoline-mediated vasoconstriction in SRN but not in SSH. 
Exposure to L-NAME potentiated cirazoline-induced vasoconstriction in SRN but not in 
SSH rats. The absence of Cl- significantly inhibited the potentiating effect ofL-NAME at 
the higher doses of cirazoline in SRN without any effects in SSH. The presence of 
niflumic acid significantly inhibited cirazoline-mediated vasoconstriction, the inhibition 
being more pronounced' in SRN than SSH. Niflumic acid did not produce any additional 
inhibitory effect in Cl--free medium. 
The resting Em of smooth muscle cells in superior mesenteric artery was not different 
I 
in SRN and SSH. Cirazoline did not produce a membrane depolarization in smooth 
muscle cells from either strain. Removal of Cl- from the extracellular space produced a 
significant depolarization which was significantly larger in SSH than SRN. Addition of 
L-NAME in normal Krebs resulted in significant depolarization in tissues from SRN but 
not in SSH. 
There was a lack of increased reactivity and magnitude in vasoconstrictor response to 
cirazoline in mesenteric blood vessels in SSH. The absence of increased reactivity in 
blood vessels from SSH can be attributed to receptor desensitization, morphology, and 
resting E111 • Cl- handling and Ca2+ -dependent Cl channel activity seem to undergo 
modification as a consequence of salt-induced hypertension. The dysfunction of the NO 
system and Cl- channels could contribute to the hypertension observed in the SSH model. 
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1. INTRODUCTION 
The cardiovascular system is composed of the heart and the blood vessels. The heart is a 
pump that supplies the body with blood, which is distributed throughout the body by a 
network of blood vessels. The cardiovascular system provides a blood supply that 
maintains an optimal environment for the body tissues by supplying oxygen and nutrients 
and removing waste products. Any disease condition such as hypertension can cause 
abnormalities in this system. Blood pressure in a vessel is generated by, and is 
proportional to, the output of the heart (cardiac output) and the resistance to flow in the 
( 
system. Blood pressure can be raised by increasing cardiac output and/or total peripheral 
resistance . 
The dynamics of blood flow through blood vessels can be best illustrated using Ohm's 
law. Essentially, Ohm's law states that potential difference (L1P) between two points is 
equal to the products of current (flow of electrons) (I) and resistance to flow (R) (L1P = I x 
R). Thus, by comparison, flow of fluids (F) through a pipe (blood vessel) is determined 
by two factors: the pressure difference (gradient) (L1P) between the two points in the 
vessels, which is the force that pushes the fluid through the pipe, and the resistance (R) to 
that flow, as defined by the equation R = L1PIF (Tabrizchi and lida, 2004). Thus the flow 
through a blood ve~sel is dependent on the blood pressure and/or total peripheral 
resistance. 
2 
1.1. Blood Vessels 
The following is a textbook summary (Seeley et al., 1989; Tortora and Grabowski, 1993). 
Blood vessels are an important component within the circulatory system. There are two 
main types of blood vessels, namely arteries and veins. The blood vessel walls consist of 
three relatively distinct layers (from the lumen to the outer wall ofthe blood vessels), 
which are tunica intima., tunica media and tunica adventitia. The tunica intima which 
lines the internal surface of the vessel, usually the thinnest constituent layer, consists of a 
single layer of endothelial cells mounted on a basement membrane (or basal lamina) and a 
I 
layer of elastic tissue called the internal elastic lamina. The tunica media contains 
predominantly smooth muscle cells and elastin fibers. Circumferentially arranged smooth 
muscle cell layers tend to be more highly organized in larger arteries owing to the 
function that these vessels play in the movement of large volumes of blood. At the outer 
border of the tunica media is an external elastic lamina, which separates the tunica media 
from the tunica adventitia and also provides structural support. The last and outermost 
layer of the blood vessel is the tunica adventitia that is composed of connective tissues 
and collagen. Both lymphatic and nerve plexus are observed in the adventitia (for review 
see Burnstock eta!., 1984). 
Arteries can be classified into two distinct types: elastic and muscular. Elastic or 
conducting arteries are present near the heart and other organs that are associated with the 
movement of large volumes of blood. These types of arteries, such as the aorta, superior 
mesenteric artery, carotid artery are composed of many layers of perforated elastic 
3 
membrane and are therefore particularly adapted to accommodate large changes in blood 
volume such as those typically associated with ejection from the left ventricle of a beating 
heart. The highly elastic nature of the walls ofthese blood vessels provides an important 
function to the smaller blood vessels -they effectively damp the large oscillations in 
blood flow and provide for a more continuous movement of blood away from the heart. 
The function of muscular or distributing arteries, such as the large and small mesenteric 
arteries, renal arteries, Gerebral arteries is to ensure the rapid and complete distribution of 
blood to all organs and tissues. These arteries contain discontinuous elastic fibers within 
the large layer of smooth muscle cells. In fine distributing arteries, the number of layers 
I 
of smooth muscle cells decreases. Terminal arterioles, which have only a single layer of 
smooth muscle cells, give rise to capillaries that are devoid of smooth muscle (for review 
see Pugsley and Tabrizchi, 2000). Individual arterial and arteriolar smooth muscle cells 
have lengths of 40-60 ).liD and diameters near the nucleus of 4 ).lm; the cells taper toward 
their ends (Hua and Cragg, 1980). 
1.2. Vascular Smooth Muscle Cells 
Smooth muscle is a major component in the wall of all blood vessels. These single 
(uninuclear), non-striated cells have abundant caveolae and numerous cell-to-cell 
junctions. Cell-to-cell junctions serve two fundamental functions- mechanical coupling, 
and excitation coupling (Gabella, 1994). Smooth muscle contains both actin and myosin 
4 
protein filaments, similar to skeletal muscle, which plays an important role in excitation-
contraction coupling (Schoenberg and Haselgrove, 1974). 
1.2.1. Membrane properties 
As with all cells, vascular smooth muscle cells maintain large ionic gradients across their 
membranes (for review see Hirst and Edwards, 1989). The unequal distribution ofK+, 
Cl-, Na+ and Ca2+ across the arterial and arteriolar smooth muscle cell membranes results 
in a resting membrane potential of approximately in the range of -55 to -75 m V (Casteels 
et al. , 1977a; Kuriyama and Suzuki, 1978; Bolton eta!., 1984)(Table 1). There is a 
f 
general agreement that resting vascular smooth muscle membranes have a higher 
permeability to K+ than they do to cr, Na+ or Ca2+ (Hirst and Van Heiden, 1982). The 
observed values of resting membrane potential of arteries and arterioles are consistent 
with their membrane being more permeable to K+ than to other ions (i.e. Na+, Ca2+). 
1.2.2. Receptors 
Cellular communication can occur via the interaction of endogenous and/or exogenous 
chemical mediators with the surface of cells. These endogenous mediators interact with 
specific sites on the cell membrane known as receptors. The cellular responses to 
receptor activation vary considerably according to the structure and nature of the receptor. 
There are four types of mechanisms by which receptor activation transmits the 
information (i.e., signal transduction). These include guanine nucleotide binding protein 
Table 1 
Ion concentrations inside [X]i, outside [X]0 , and equilibrium potential (Ep) in vascular 
smooth muscle cell (for review see Hirst and Edwards, 1989) 
Ions [X]i, (mM) [X]o, (mM) Ep, (mV) 
Sodium (Na+) 10 - 20 ~ 150 +50 
Potassium (K+) 130 - 160 3-5 -90 
Chloride ( Cq 40-70 ~ 140 -20 
Calcium (Ca2+) 10-6 - 10-8 M ~ 2 > + 150 
5 
6 
(G-protein) coupled receptor, DNA-coupled receptor, receptor directly coupled to 
enzymes, and receptor coupled directly to ion channels (Walker et al., 2002). 
G-protein coupled receptors are located in the cell membranes and are composed of seven 
transmembrane helices (I-VII) (for review see Gilman, 1987). In the resting state, the 
receptor is bound to a G-protein that holds the receptor in an inactive conformation. The 
G-protein is composed of three subunits (e.g, a,~' y). In the resting state, the three 
subunits are bound together, and guanine nucleotide diphosphate (GDP) is tightly bound 
to the a-subunit of the G-protein (for review see Kaziro et al., 1991 ). When an agonist 
( 
interacts and activates a G-protein coupled receptor, a conformational change in the 
receptor leads to the activation of the G-protein. Activation of G-proteins involves the 
release of GDP and binding of guanine nucleotide triphosphate (GTP) to its a-subunit and 
the dissociation of this subunit from the ~y-subunit heterodimer (Kahn and Gilman, 
1984). The a and ~y subunits are then believed to activate a number of effector 
molecules. The a subunit then hydrolyzes GTP to GDP, which in turn inactivates the a-
subunit, allowing it to reassociate with the ~y complex, rendering the G-protein inactive. 
Stimulation or inhibition of G-proteins results in activation of other enzyme systems such 
as adenylyl cyclase or phospholipase C (PLC) (for review see Gilman, 1987). This 
initiates the sequence of events that constitutes G-protein-coupled receptor transduction 
(for review see Birnbaumer, 1990). Examples of G-protein receptors include the ~2- and 
a1A-adrenoceptors (Shaw and McGrath, 1996). 
7 
DNA-coupled receptors are intracellular receptors mainly composed of nuclear proteins. 
Therefore, agonists have to enter the cell membranes in order to interact with this type of 
receptor. Agonist binding to the receptor causes a conformational change in the receptor 
molecule, which results in dissociation of the receptor from the inhibitory molecule. One 
example of a DNA-coupled receptor is illustrated by a steroid molecule that enters a cell 
and binds to a cytoplasmic receptor and dissociate the inhibitory molecule, heat shock 
protein 90, bound to it ~nd thus activate the receptor (Howard and Distelhorst, 1988). 
Enzymes that are part of the cell membrane can have sites for agonists to interact. An 
f 
example of the latter is the tyrosine kinase receptor, which is involved in the regulation of 
growth, cell differentiation, and responses to metabolic stimuli (Shaw and McGrath, 
1996). This receptor consists of an external moiety which contains the agonist 
recognition site and a cytosolic region which incorporates a tyrosine kinase enzyme. 
Agonists such as insulin, epidermal growth factor, and platelet-derived growth factor bind 
to the receptor and induce a conformational change and subsequently activate the tyrosine 
kinase enzyme (Baron et al. , 1990). 
Receptors can also be directly linked to ion channels or alternatively be part of an ion 
channel. This type of receptor is composed of subunits, each of which has four 
transmembrane domains. Each receptor-coupled channel possesses, as part of their 
structure, an extracellular ligand-binding site. When an endogenous ligand or certain 
drugs bind to the receptor, it initiates a conformational change in other parts of the 
receptor-operated channel entity that leads to the opening of a central ion-selective pore . 
..., 
Thus, the passage of ions occurs only when the pore is open and the receptor activated. 
Examples of receptor operated ion channels include K channels, Ca channels, Na 
channels, and nicotinic receptor (Ch,angeux et al., 1987). 
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Therefore, the release of neurotransmitters from nerve endings, circulating humoral 
factors, and/or locally released mediators can bind and activate specific receptors located 
on the smooth muscle or endothelial cells. Some examples of receptors associated with 
smooth muscle cells include adrenoceptors, 5-hydroxytryptamine receptors, muscarinic 
receptors, histamine receptors, angiotensin receptors, vasopressin receptors, and 
prostanoid receptors (Shaw and McGrath, 1996). Furthermore, endothelial cells ~lso 
contain several receptors such as angiotensin receptors, adenosine receptors, 
acetylcholine receptors, purinoceptors, and neuropeptide receptors (for review see 
Tabrizchi, 2003). Each receptor can be further subdivided depending on the rank order of 
agonist potency, affinity of an antagonist, pharmacological profile, and/or signaling 
pathway (Shaw and McGrath, 1996). As a historical example, adrenoceptors were 
classified as either a or~ each being associated with excitation (vasoconstriction) or 
inhibition (vasorelaxation), respectively (Ahlquist, 1948). a-Adrenoceptors are further 
subdivided into a, and a2, whereas ~-adrenoceptors are subdivided into ~ 1 , ~2, ~3, and ~4 
receptors (for review see Minneman, 1988). 
Further sub-classification of subtypes of a 1 and a 2 adrenoceptor have been made. These 
subtypes have been found to be present in vascular smooth muscle cells. At present, 
9 
based on pharmacological and biochemical evidence, there appear to be at least three 
different subtypes of the a 1-adrenoceptor that contribute to contractile responses in 
smooth muscle. These are a 1A, a 18, and am adrenoceptors (for review see Minneman, 
1988). According to the convention, capital letter subscripts (e.g., a 1A, alB, am) are used 
to denote receptors identified from functional/binding studies whereas small letter 
subscripts (e.g. , a 1a, a,b, aid) are used to denote cloned receptors. It has been suggested 
that in rat mesenteric artery, mixtures of a 1A and a 1s adrenoceptors are present (Han et 
al. , 1990). Kong eta!. ( 1994) have suggested that in the rat mesenteric vasculature the 
a 1A adrenoceptor subtype is predominant and is highly sensitive to antagonism by 5-
I 
methylurapidil, an a 1 A adrenoceptor-selective antagonist. Williams and Clarke (1995) 
supported the latter view that vasoconstrictor responses via the activation of a 1-
adrenoceptors in rat mesenteric blood vessels are mediated as a result of activation of 
a1 A-adrenoceptor subtypes. In contrast, Hussain and Marshall (2000) have suggested that 
the contractions of the rat mesenteric artery are mediated via the am and possibly a 18 
adrenoceptor. A study using human cloned a 1-adrenoceptors indicated that cirazoline, an 
a 1-adrenoceptor agonist, has a higher affinity for the a 1a subtype than a 1b and a 1d 
subtypes (Horie et al. , 1995). Taken together, the current views suggest that cirazoline-
induced vasoconstriction is mediated principally via the activation of a 1A-adrenoceptor 
subtype in mesenteric blood vessels (Kong eta!. , 1994; Horie eta!. , 1995; Williams and 
Clarke, 1995). 
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1. 2. 3. Membrane ion channels in vascular smooth muscle cells 
The vascular smooth muscle cell membrane is believed to be spanned by a number of 
different ion chrumels, which act in a co-ordinated fashion to regulate ion influx or efflux, 
thereby contributing to the control of the intracellular ion concentrations, and hence 
tension development and vascular constriction and relaxation (Aaronson and Smimov, 
1996). 
1.2.3.1. K channels: Most vascular smooth muscle have a resting membrane potential 
close to the equilibrium K+ potential, which means that the K+ permeability is mainly 
f 
responsible for setting the resting potential (for review see Nelson and Quayle, 1995). 
Four major classes ofK channels/currents have been distinguished in vascular smooth 
muscle cells, namely voltage-dependent K channels (Kv), Ca2+- and voltage-sensitive K 
channels (Kca), ATP-sensitive K channels (KATP) and inward rectifier K channels (K1R) 
(Aaronson and Smimov, 1996). Kv channels open when the membrane potential of the 
cell is depolarized (Beech and Bolton, 1989). The voltage at which this current is 50% 
activated is - 10 mV and the range of inactivation voltage is - 25 to -45 mV (Robertson 
and Nelson, 1994). 4-Aminopyridine is perhaps the most selective inhibitor of Kv 
channels in vascular smooth muscle (Robertson and Nelson, 1994). Kca channel opening 
was observed at membrane potentials between -60 and - 50 m V when intracellular Ca2+ 
was between 1 o-8 and 1 o-7 M, and open probability increased steeply with membrane 
depolarization (Benham et al. , 1986; Gel band et al. , 1989). It is known that 
tetraethylammonium is a relatively selective blocker ofKca channel (Benham and Bolton, 
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1986). KATP channels are inhibited by intracellular A TP and are considered to be a link 
between cellular metabolism and electrical events (Ashcroft and Ashcroft, 1990). The 
KA TP channel in vascular smooth muscle is the main target for the vasodilators such as 
pinacidil and cromakalim (Weston, 1989). Glibenclamide and tolbutamide are proposed 
to be selective blockers ofKATP channels (Standen et al., 1989). K1R channel in vascular 
smooth muscle conducts inward current at membrane potential negative to the K 
equilibrium potential and smaller outward current at membrane potential positive to K 
equilibrium potential (Edwards et al., 1988). The K1R channel is very sensitive to 
inhibition by extracellular Ba2+ (Quayle eta/., 1993 ). 
1.2.3.2. Ca channels: Two types of voltage-operated Ca channels, namely L-type and T-
type have been described in a variety of vascular smooth muscle cells (Benham et al., 
1987; Aaronson et a/. , 1988). The L-type Ca channels are characterized by a relatively 
slow inactivation, a greater permeability to Ba2+ than to Ca2+, a high sensitivity to 
dihydropyridines, a unitary conductance of 15-28 pS in 80-110 mM Ba2+, and a voltage 
range of activation of -60 to -40 m V (for review see Bean, 1989). T -type Ca channels 
are characterized by rapid inactivation, a small (6-8 pS) unitary conductance, and voltage 
ranges of activation and inactivation, which are more negative ( -70 to -50 m V) than 
those of the L-type channels. In addition to the two types of voltage-operated channel, a 
third type of Ca chrumel, the so called receptor-operated Ca channel, has been identified 
in smooth muscle cells. The latter channel has been suggested to be responsible for 
causing both direct Ca2+ influx and depolarization leading to indirect Ca2+ influx via 
voltage-gated Ca channels (Bolton, 1979). 
1.2.3.3. ci+-dependent Cl channels: An increase in intracellular Ca2+ concentration is 
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an essential prerequisite for activation of Ca2+ -dependent Cl currents (for review see 
Large and Wang, 1996). It was reported that in rat lacrimal gland cells, the threshold 
concentration of intracellular Ca2+ for activation of Ca2+ -dependent Cl current was 100 
nM to 111M (Marty et al., 1984 ). Single Cl channel activity was recorded (in response to 
caffeine) from myocytes of human mesenteric artery, and their single channel 
conductance was estimated to be 2.8 pS (KlOckner, 1993). The half-duration of 
spontaneous transient inward currents (STICs), which are believed to be a Ca2+-dependent 
Cl current, in guinea-pig mesenteric vein was reported to be 390 ms at -70 mV (Van 
Heiden, 1991). However, Hogg et al. (1993) has reported that the time constant of decay 
of STICs was 86 ms at -50 m V and that this time constant increases with depolarization 
in rabbit portal vein. The opening of Ca2+ -dependent Cl channels is believed to be 
responsible for membrane depolarization and thus further activates voltage-operated Ca 
channels (for review see Large and Wang, 1996). This has been further discussed in 
detail in section 1.5. 
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1.3. Excitation-Contraction Coupling of Vascular Smooth Muscle 
Many aspect of excitation-contraction coupling in smooth muscle have been studied. It is 
recognized that smooth muscle cell contain actin and myosin filaments (regulatory 
subunits), and that these filaments are responsible for the contractile process (for review 
see Horowitz eta!. , 1996). The contractile process is activated by Ca2+, and it is an 
energy-dependent proce$S requiring the degradation of adenosine 5-triphosphate (ATP). 
The process of excitation-contraction in smooth muscle can be initiated by interaction of 
endogenous mediators with membrane-bound receptors located on the cell surface 
, 
(Sneddon and Burnstock, 1984). In addition, processes such as shear stress can also 
initiate contraction or relaxation of vascular smooth muscle cells (for review see Bevan, 
1997). 
Vascular smooth muscle contraction is mediated, in part, by electromechanical and/or 
pharmacomechanical coupling (Somlyo and Somlyo, 1968). Electromechanical coupling 
is associated with membrane depolarization, which ultimately leads to contraction, 
whereas pharmacomechanical coupling is believed to occur independent of changes in 
membrane potential (Bolton, 1976; for review see Bolton and Large, 1986). Sympathetic 
nerve stimulation releases various neurotransmitters, which can initiate contraction by 
three different mechanisms. Neurally released noradrenaline is believed to activate the a-
adrenoceptors, which are coupled to G-proteins, and subsequently activate the enzyme 
PLC. PLC subsequently hydrolyses the membrane bound inositol phosphates which 
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eventually leads to the formation of inositol triphosphate that releases Ca2+ by acting on 
the receptor on sarcoplasmic reticulum (Van Heiden, 1991). This mechanism does not 
rely on a change in the membrane potential of the vascular smooth muscle cells. 
Alternatively, sympathetic nerve stimulation may activate a pathway which does not 
involve a-adrenoceptors (Hirst and Lew, 1987). Sympathetic nerves releases a 
cotransmitter, probably ATP (Sneddon and Burnstock, 1984). ATP then activates a set of 
purinoceptors, which are linked to cation-selective channels, so producing a membrane 
depolarization. This depolarization triggers the opening of the voltage-dependent Ca 
channels present in the membranes of vascular smooth muscle cells (for review see Hirst 
f 
and Edwards, 1989). Thirdly, sympathetic nerves may release vasoactive peptides (e.g., 
neuropeptide Y), which produce persistent vasoconstriction of vascular smooth muscle 
cells (for review see Wharton and Gulbenkian, 1987). 
1.3.1. Structure ofsympathetic axons 
The nerves supplying blood vessels are unmyelinated and form a plexus of branching 
varicose axons. The plexus in most blood vessels is situated in the outermost layer of the 
vessel wall, the adventitia, outside of the layer of contractile smooth muscle cells (the 
media) (Appenzeller, 1964; Bumstock and Costa, 1975). Hence, in vessels with several 
layers of smooth muscle cells only the muscle cells at the media-adventitial border can be 
in direct contact with the axons. There are some exceptions where axons have been 
reported to ramify the outer two or three layers of smooth muscle cells of some arteries 
and veins. The axon plexus around blood vessels is predominantly composed of 
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sympathetic postganglionic axons. Most sympathetic axons are grouped in bundles 
(Burnstock and Costa, 1975). Each axon bundle is surrounded by a layer of basal lamina, 
which consists oftypes IV and V collagens, laminin, entactin, and heparan sulfate (for 
review see Bunge et al. , 1986). Sympathetic varicosities contain numerous vesicles, one 
or two mitochondria, and some smooth endoplasmic reticulum. Vesicles within the 
varicosities contain neurotransmitter and consequently are believed to be sites for 
neurotransmitter release ,(for review see Geffen and Livett, 1971). Three types of vesicles 
are found in sympathetic varicosities, many granular and agranular small vesicles (30-60 
nm in diameter) and a few dense-cored vesicles (60-150 nm in diameter) (for review see 
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Geffen and Livett, 1971). There is substantial evidence to show that noradrenaline, ATP, 
and neuropeptide Y are cotransmitters in sympathetic nerves (for reviews see Bumstock, 
1976, 1990). Numerous studies have also demonstrated that cotransmission of 
noradrenaline and A TP also occurs in many different blood vessels in a variety of species 
(for review see Bumstock, 1990). Following release from sympathetic nerve terminals, 
noradrenaline and A TP elicit vasoconstriction of the smooth muscle via an action at a-
adrenoceptors and purinoceptors, respectively (Hirst and Jobling, 1989). The evidence in 
the literature supports the view of the existence of neuromuscular junction between the 
varicosities and vascular smooth muscle cells (Luff et al. , 1987). 
1.3.2. Neuromuscular transmission involving the activation of a-adrenoceptors 
In pulmonary arteries and veins, sympathetic nerve stimulation produces membrane 
depolarizations that last for many seconds (Suzuki, 1981 , 1983 ). When triggered by only 
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a few stimuli, the membrane potential changes occur after a long latency (1-2 sec) and are 
of small amplitude (2-3 m V). Repetitive nerve stimulation causes larger more sustained 
depolarizations but the latency to onset remains unchanged (Suzuki, 1981 ). In both types 
of vessels the potential change becomes complex, often a transient component occurs at 
the start of the response, and it is followed by the sustained component. Both of the 
components are blocked by a-adrenoceptor antagonist, phentolamine (Suzuki, 1981). 
Suzuki ( 1981) has demonstrated that phentolamine suppressed the depolarizing action of 
noradrenaline in mesenteric vein from guinea-pigs. The process of neuromuscular 
transmission has been analyzed in detail in mesenteric veins (Van Heiden, 1988). In 
, 
these vessels an ongoing discharge of spontaneous transient depolarizations are detected. 
Spontaneous transient depolarizations increase in frequency shortly after a period of 
sympathetic nerve stimulation, thus summing to give the slow excitatory junction 
potential. However, spontaneous transient depolarizations do not result from the 
spontaneous release of quanta of transmitter from sympathetic nerve terminals; rather 
they appear to result from the irregular pulsatile release of Ca2+ from internal stores (Van 
Helden, 1991). After release from the internal stores, Ca2+ activates a set ofCI selective 
channels present in the membranes of these cells (Van Helden, 1991 ). This results in an 
increase in CJ conductance which leads to depolarization. Taken together, activation of 
a~adrenoceptors seems to release Ca2+ from intracellular stores which leads to contraction 
of vascular smooth muscle cells via (a) activating a contraCtile system, and (b) activating 
Cl channels, which results in depolarization and further increases Ca2+ influx. 
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1. 3. 3. Neuromuscular transmission involving the activation of purinoceptors 
In all mammalian arteries sympathetic nerve stimulation triggers a sequence of membrane 
potential changes. A single sympathetic nerve stimulus initiates a membrane 
depolarization, termed an excitatory junction potential ( e.j .p.) (Bell, 1969; Hirst, 1977). 
E.j.ps by themselves do not initiate contraction, rather several e.j .ps must sum up to give a 
depolarization of some 15-20 m V before threshold is reached for voltage-dependent Ca 
channels to be activated. (Hirst, 1977; for review see Hirst and Edwards, 1989). When 
this occurs a contraction ensues. If the stimulus is applied close to the recording point, 
e.j .ps are seen to have short latencies, 10-20 ms. Typically such e.j.ps have a total 
I 
duration of about 1 s. For example, an e.j.p. recorded from a submucosal arteriole has a 
time to peak potential of 100 ms and then decays with a time constant of 500 ms (Hirst 
and Neild, 1978). The time course of the excitatory junctional current, underlying an 
e.j .p. is brief. When measured directly from submucosal arterioles using a single 
electrode voltage-clamp technique the peak current occurred after 10 ms and with a total 
duration of about 200 ms (Finkel et al. , 1984). After the peak, the decay of current could 
be described by a single exponential with a time constant of 50 ms. These observations 
indicate that the long time course of an e.j .p. reflects the long membrane time constant of 
arteriolar smooth muscle cell. Clearly, since one frequently has to sum together 
successive e.j.ps to reach threshold for the initiation of voltage-dependent Ca2+ entry, any 
agent which makes the membranes of arteries more depolarized will make it more 
unlikely that this threshold is reached. The amplitudes of excitatory junctional currents 
depend upon the membrane potential at which they are recorded. They increase linearly 
with hyperpolarization and decrease linearly with depolarization (Finkel et al., 1984 ). 
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Their reversal potential, the membrane potential where inward current just equals outward 
current, is about 0 mV (Finkel et al. , 1984). 
Most muscle cells in an arteriole are directly innervated and hence may be directly 
activated by action of transmitters upon them. However in larger vessels most cells are 
not directly innervated with the innervation being restricted to the media-adventitial 
border (Burnstock and Costa, 1975). For the membrane potentials of all cells to be 
changed during sympathetic neuromuscular transmission, some of the junctional current 
generated on the outer most layer of muscle cells must flow to the deeper non-innervated 
I 
cells. This occurs because individual vascular smooth muscle cells are electrically 
connected via gap junctions to their neighboring cells (Brink, 1998). Such electrical 
coupling has been demonstrated in many preparations (e.g., coronary artery, mesenteric 
artery) (Beny and Pacicca, 1994; Yamamoto et al., 1999). The analyses show that many 
arterial preparations behave as simple linear cables with electrical length constants in the 
range of0.3- 1.5 mm (Bolton, 1974; Casteels et al. , 1977a). Electrical coupling between 
arteriolar cells has been demonstrated more directly using two independent intracellular 
electrodes, one to pass current and the other to record differences in the potential (Hirst 
and Neild, 1980). It should be noted that as individual cells have circumferential 
organization, the two electrodes could not have been in the same cell. When a small 
current was passed through one electrode; it caused a membrane potential change at the 
second electrode. Again some of the injected current must have flowed to the recording 
point via gap junctions between cells (Smeda and King, 1998; Brink, 1998). 
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1. 3. 4. Changes in membrane potential 
Vascular smooth muscle cell contraction may or may not be associated with membrane 
depolarization. There are a number of observations reported where there were significant 
depolarizations associated with contraction after the application of an a-adrenoceptor 
agonist (Suzuki, 1981; Mulvany et al., 1982; Haeusler and De Peyer, 1989). For 
example, the membrane potential of smooth muscle cells from guinea-pig mesenteric vein 
became significantly depolarized by the application of noradrenaline (from - 64.2 ± 2.3 to 
-50.2 ± 2.5 m V) (Suzuki, 1981 ). In addition, Mulvany et al. (1982) have also 
demonstrated that membrane potentials (- 59.2 ± 0.4 mV) from rat small mesenteric 
arteries (second or third order vessels) were depolarized (-33.7 ± 1.0 mV) following the 
addition of noradrenaline (1 0 J.tM). Thus, it has been suggested that activation of a-
adrenoceptor in vascl.\lar smooth muscle produces depolarization of a magnitude close to 
~14 mV. 
Interestingly, several other studies have shown that smooth muscle contraction could be 
mediated without depolarization (Suet al., 1964; Somlyo and Somlyo, 1968; Matthews et 
al. , 1984; Frieden and Beny, 1995). For example, Suet al. (1964) using glass 
microelectrodes have demonstrated that there was no change in membrane potential 
during contraction by sympathetic nerve stimulation or noradrenaline application in rabbit 
pulmonary artery. Somlyo and Somlyo (1968) using the sucrose-gap method, have also 
reported that the contraction produced by noradrenaline in rabbit pulmonary artery is not 
associated with depolarization. Evidence suggest that noradrenaline can .cause 
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contraction of pulmonary arteries without depolarization (Casteels et al. , 1977b ). 
Therefore, it seems that in some types of arteries, certain agonist-mediated contractions of 
vascular smooth muscle can occur independent of changes in membrane potential. This 
process is known as pharmacomechanical coupling. Therefore, based on the evidence it 
can be concluded that electromechanical and pharmacomechanical coupling may act 
synergistically or they may be complementary to each other in promoting 
vasoconstriction. 
1.3.5. Cell signaling pathways 
( 
A vast array of agonists regulate smooth muscle function by interacting with specific 
receptors located on the cell membrane. The resultant effect is the activation of 
intracellular signaling pathways and the formation of a number of key second 
messengers. In addition, other endogenous molecules such as nitric oxide can alter 
smooth muscle cell tone by initiating cell signaling directly through non-receptor-
mediated mechanisms. In Figure 1 the current and recognized signaling pathways in 
smooth muscle cells have been summarized. 
In the late 70s and early 80s Berridge and coworkers identified the hydrolysis of inositol-
containing phospholipids as a universal signaling pathway activated in response to Ca2+ 
mobilizing agonists (Fain and Berridge, 1979; Irvine et al., 1982; for review see Berridge 
and Irvine, 1989). Following receptor activation, membrane-bound inositol lipid, 
phosphatidylinositol 4,5-biphosphate is hydrolysed by a phosphoinositide-specific PLC to 
generate two second messengers, inositol 1 ,4,5-triphosphate (IP3) and 1 ,2-diacylglycerol 
Figure 1: Simplified schematic diagram summarizing some ofthe receptors and various 
transduction mechanisms which regulate vascular smooth muscle tone. 
[Ca2+]i, intracellular Ca2+ concentration; [Ca2+]0 , extracellular Ca2+ concentration; AC, 
adenylyl cyclase; ATP, adenosine 5-triphosphate; C, contraction; CaATPase, calcium 
ATPase enzyme; CaM, calmodulin; cAMP, cyclic adenosine 3,5-monophosphate; cGMP, 
cyclic guanosine 3,5-monophosphate; DAG, diacylglycerol; GC, guanylyl cyclase; Gp, G-
protein; G5, stimulatory G-protein; GTP, guanine nucleotide triphosphate; InsP2, 
phosphatidylinositol 4,5-biphosphate; IP3, inositol 1 ,4,5-triphosphate; KATP, ATP-
sensitive K channels; MLCK-, inactivated myosin light chain kinase; MLCK+, activated 
. 
myosin light chain kinase; NO, nitric oxide; PKA, protein kinase A; PKC, protein kinase 
C; PKG, protein kinase G; PLC, phospholipase C; R, receptor; ROC, receptor-operated 
Ca channel; SR, sarcoplasmic reticulum; VOC, voltage-operated Ca channel. 
Solid lines represent pathways mediating contraction and dotted lines represent pathways 
leading to relaxation. 
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(DAG). These messengers are generated by membrane transduction processes where the 
agonist-receptor complex is transduced via the activation of a heterotrimeric G-protein 
(for review see Gilman, 1987). IP3 stimulates the release of Ca2+ from intracellular Ca2+ 
stores through interaction with specific IP3 receptors located on the sarcoplasmic 
reticulum (Berridge, 1993). After release in response to IP3, Ca2+ binds to calmodulin 
(CaM) inducing a conformational change, which allows the Ca2+-CaM complex to bind to 
and activate myosin light chain kinase (MLCK) (Dabrowska et al., 1978). The active 
kinase (Ca2+-CaM-MLCK) catalyzes the phosphorylation of myosin at Ser-19 of the two 
20-kDa light chain subunits of myosin. This triggers cross-bridge cycling and the 
I 
development of force or shortening of the muscle (for reviews see Walsh, 1994; Arner 
and Malmqvist, 1998). Relaxation is achieved by extrusion of Ca2+ from the cell or 
uptake into the sarcoplasmic reticulum, where upon Ca2+ dissociates from CaM and the 
inactive apoenzyme of MLCK is regenerated. Myosin is dephosphorylated by myosin 
light chain phosphatase and the muscle relaxes (for review see Walsh, 1994). In agonist-
stimulated (angiotensin II, vasopressin) smooth muscle cells it was observed that IP3 
formation is transient while DAG formation is sustained (Griendling et al., 1986; Sunako 
et al., 1990). It has been established that phosphatidylcholine (PC) hydrolysis provides 
the majority ofDAG formed (Lassegue et al. , 1991; Plevin and Wakelam, 1992). DAG 
may be derived from PC by two main routes, (1) a phospholipase D catalysed pathway, 
which generates phosphatidic acid which can then be converted to DAG by phosphatidic 
acid phosphohydrolase, and (2) a route that directly generates DAG via the putative PC-
PLC enzyme, which is distinct from phosphoinositide-specific PLC (Lassegue et al., 
1991 , 1993 ). The main physiological target of DAG is a family of phosphatidyl serine-
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dependent serine/threonine-directed kinases collectively called protein kinase C (PKC) 
(Lassegue et al. , 1993 ). Thus DAG is believed to play a role in contraction by activating 
PKC enzyme which initiates signal transduction mechanisms. 
Sensitization of contractile elements in vascular smooth muscle cells can result in an 
enhanced contraction at a given intracellular Ca2+ concentration. This can be achieved 
through an inhibition of myosin light chain phosphatase (Somlyo and Himpens, 1989) 
and involves the activation of a small molecular weight G-protein (Kitazawa et al., 1991; 
Hirata et al. , 1992). These monomeric proteins are derived from Ras-related low 
f 
molecular mass GTPases ofthe Rho subfamily (Pfitzer and Arner, 1998). PKC appears 
to play a role in the G-protein-mediated sensitization of smooth muscle contraction (Sato 
et al. , 1994 ). It has been suggested that PKC is involved in activation of G-protein by 
exchanging GTP for GDP (Antonietta DeMatteis et al., 1993). This activated small G-
protein might be involved in phosphorylating myosin light chain phosphatase and thus 
causing sensitization of the contractile element. Thus it can be summarized that although 
Ca2+ is the major physiological regulator of smooth muscle contraction, the Ca2+ 
sensitivity of the regulatory/contractile apparatus can be modified by other mechanisms. 
1.4. Vascular Smooth Muscle Relaxation 
It is now generally accepted that cyclic adenosine 3,5-monophosphate (cAMP) and cyclic 
guanosine 3,5-monophosphate (cGMP) are intimately involved in initiating relaxation in 
vascular smooth muscle (for review see McDaniel et al. , 1994). The intracellular levels 
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of cAMP and cGMP are regulated by the enzymes, adenylyl cyclase and guanylyl 
cyclase, respectively, as well as by the cyclic nucleotide phosphodiesterases, a family of 
isoenzymes which degrade these cyclic nucleotides (for review see Polson and Strada, 
1996). A major role for the adenylyl cyclase/cAMP signaling system in relaxation is 
implicated by agonists such as adrenaline, prostacyclin, adenosine, and vasoactive 
intestinal peptide, which raise intracellular cAMP levels and evoke relaxation of vascular 
smooth muscle (Holzmann eta!., 1980; Ganz et al., 1986; Hessen and De Mey, 1990). 
The effects of cAMP are thought to be mediated through the activation of a family of 
cAMP-dependent protein kinases designated as PK.A (Parks et al., 1987). The proposed 
I 
mechanisms of cAMP-induced relaxation include (i) reduction in myoplasmic Ca2+ by a 
decrease in Ca2+ influx (Chen and Rembold, 1992), (ii) increase in Ca2+ efflux (Hoshi et 
al. , 1988), (iii) sequestration of Ca2+ into internal stores (Tawada et al., 1988), (iv) 
activation of PKA, which could alter the Ca2+ sensitivity of phosphorylation by 
phosphorylation of either MLCK (Adelstein et al. , 1978, 1981) or myosin light chain 
phosphatase, and/or (v) activation of cGMP-dependent protein kinase (PKG) which could 
mediate the relaxation (Lincoln, 1989). 
A number of studies have demonstrated that cAMP may relax smooth muscle by 
mechanisms that decrease the intracellular Ca2+ (Abe and Karaki, 1989; Kimura et al. , 
1982). In porcine carotid artery, relaxations induced by low concentrations of forskolin 
were associated with significant decreases in myoplasmic Ca2+ without changes in the 
relationship between Ca2+ and myosin phosphorylation (McDaniel et al., 1991 ). De 
Lanerolle eta!. (1984) reported that MLCK could be phosphorylated by PK.A. 
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Phosphorylation of MLCK would decrease the affinity of MLCK for the Ca2+ -CaM 
complex, resulting in lower levels of myosin kinase activity for a given level of Ca2+ (i.e., 
a decrease in the Ca2+ sensitivity of phosphorylation). The net effect is to reduce the Ca2+ 
sensitivity of the contractile apparatus and favor relaxation (Adelstein et al. , 1978). Thus 
cAMP can mediate vascular smooth muscle relaxation by either reducing intracellular 
Ca2+ concentration, decreasing Ca2+ sensitivity of the contractile elements, or a 
combination of the two . . 
1.5. Chloride Channels 
In skeletal muscle Cl- is distributed across the cell membranes according to the Donnan 
equilibrium (Hodgkin and Horowicz, 1959). In contrast, it seems that in the smooth 
muscle cells Donnan distribution of Cl- does not exist (Casteels, 1965; Aickin and 
Brading, 1982). It would appear that the intracellular Cl- concentration is considerably 
higher in smooth muscle (34-51 mM) compared to skeletal muscle (2.4 mM) than would 
fit the theory of a passive distribution (Casteels and Kuriyama, 1966). In Table 2 the 
estimated values of intracellular Cl- concentration in various smooth muscle cells have 
been given. It has been suggested that the high intracellular Cl- concentration might be 
playing an essential role in smooth muscle cell function and, needless to say, this has 
been of considerable interest for the past four decades. Over this time span many 
suggestions have been made as to the role of Cl- in function of smooth muscle. Casteels 
(1971) has suggested that the high intracellular Cl- results from the movement of Cl- into 
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Table 2 
Estimates for intracellular Cl- concentration in smooth muscle cell 
N [Cl]i (mM) E111 (mV) Ec1 (mV) Reference 
Guinea-pig taenia coli 30 61 a -57± 0.3 -21 Casteels and Kuriyama ( 1966) 
Guinea-pig vas deferens 79 41.2 ± 6.7b -67.6 ± 7.8 Aickin and Brading (1982) 
Guinea-pig ureter 13 51.1±4.0b 
-48.7 ± 5.4 -18.6 Aickin and Vermile (1983) 
Rabbit aorta 8 32.6c -60.1 ± 2.9 Gerstheimer et al. (1987) 
Rat femoral artery 4 43.8 ± 3.5d -61.5 ± 1.3 Davis (1992) 
Rat saphenous artery 18 31.0 ± 0.5d -63.7 ± 2.4 - 42.6 Davis et al. ( 1997) 
All data are given as mean ± SEM 
alntracellular Cl- ion concentration is given in mmoles liter-1 cell water 
bUsing double barreled ion-selective microelectrode, and the value is given as activity (estimated Cli expressed as mmoles liter-' cell 
water was assumed to equal [CI]i, and this value was multiplied by the calculated activity coefficient (0.764) of the normal Krebs solution) 
cBy uptake studies using 36CI 
dUsing double barreled ion-selective microelectrode, and the value is given as concentration 
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the cells against the electrochemical gradient. Thus an active transport system was 
thought to be involved in accumulating cr inside the cells (Casteels, 1971; Aickin and 
Brading, 1982). The three mechanisms by which Cl- is thought to be accumulated inside 
smooth muscle cells are (a) chloride-bicarbonate (Cr/ HC03-) exchange, (b) sodium-
potassium-chloride (Na+ + K+ +CO cotransport, and (c) pump III (for review see 
O'Doimell and Owen, 1994). 
Chloride-bicarbonate exchange: The Cr/ HC03- exchanger is reversible and hence in 
Cl--free medium, HC03- influx and Cl- efflux was observed and this caused pH to 
f 
increase from 7.1 to pH 7.8 (Aickin and Brading, 1984). Upon readmission of Cl- into 
the extracellular compartment, pH changed from 7.8 to pH 7.1. According to Vaughan-
Jones (1979), HC03- ·is not at equilibrium due to the action ofNa+ /H+ exchange, which 
holds the intracellular pH at a more alkaline level than it would be if H+ were in 
equilibrium with membrane potential. This makes the intracellular HC03- concentration 
higher and the outward HC03- gradient provides the driving force for cr accumulation 
(for review see Chipperfield and Harper, 2000). Thus, this exchanger is believed to play 
an important role in regulation of intracellular Cl- concentration. 
Sodium-potassium-chloride cotransport: Na+ + K+ + Cl- cotransport is a symport system 
present in vascular smooth muscle cells. It has an apparent stoichiometry of 1: 1 :2, 
respectively (Owen, 1984). Although the cotransporter is bidirectional, the sum ofthe 
electrochemical gradients for the three transported ion species determines the direction of 
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net flux of ions but it mediates a modest net uptake of the transported ions (for review see 
ehipperfield, 1986). It was proposed by Davis et al. (1993) that the smooth muscle cells 
of hypertensive rats have an elevated (Na+ + K+ + er) cotransport activity that elevates 
the intracellular concentration of Cl-. This elevation in the intracellular er concentration 
in turn was suggested to act as a depolarizing influence in the cells that contributes to the 
elevated resting tension in these cells (Davis et al., 1993). Therefore, alteration in 
intracellular concentratibn of el- has been implicated as a factor influencing smooth 
muscle function in state of hypertension. 
Pump III: It has been demonstrated in conditions where neither (Na+ + K+ +en 
cotransport or enHe03- exchange could function, the intracellular er concentration 
was still above equilil;>rium. This has led to the suggestion that there must be a third 
process capable of driving the el- inwards. Its existence was demonstrated by first 
blocking (Na+ + K+ +en cotransport and enHeo3- exchange and then reducing the 
outward leak with a e1 channel blocker, with the result that intracellular el- increased due 
to action of pump III (ehipperfield et al. , 1993). Based on the current published evidence 
in the literature it can be suggested that these three transport systems together are 
responsible for the accumulation of er inside the cells. 
1.5.1. Functions of intracellular cr 
1.5.1.1. Membrane potential 
The membrane potential (Em) is given by Goldman-Hodgkin-Katz equation (Goldman, 
1943; Hodgkin and Katz, 1949): 
Em= RT/F loge (PK[K] 0 + PNa[Na]0 + Pe~[Cl]i) I (PK[K]i + PNa[Na]i + Pci[Cl]o) 
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Em is given by the weighted mean of EK, ENa, and EC/, weighted according to the relative 
conductances of the ionS'. According to the Nemst equation 
ECI = RT/F log [Cl]/[Cl]0 = 61.5 log [Cl]/[Cl]o at 37°C 
According to this equation it is evident that even if intracellular cr concentration is at 
equilibrium, the Em will be greatly depolarized from its resting value of -70 mV. Thus it 
has been suggested that if intracellular Cl- concentration is at or above equilibrium it will 
exert a depolarizing iqfluence on the membrane potential (for review see Chipperfield and 
Harper, 2000). Also the Cl- conductance reflects the degree of Cl channel opening and it 
is well established that the opening of Cl channels produces depolarization of the Em (for 
review see Large and Wang, 1996). Davis et al. (1997) has suggested that the activation 
of Cl- accumulation serves two purposes, which include (a) prevention of a fall in 
intracellular Cl- concentration which would have attenuated the depolarization, and (b) 
potentiation of the depolarization secondary to opening of Cl channels. Thus Em must 
depend on the activity of the cr -accumulating systems and there is evidence that their 
activity can be influenced by agonists which open Cl channels (Davis et a!. , 1997). 
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1.5 .1.2. Intracellular pH 
Smooth muscle cells maintain an intracellular pH which is about one unit more alkaline 
than it would be if H+ were distributed based on Em. This might be attributed to the cr I 
HC03- exchange process where HC03- accumulation derives the equilibrium towards 
H2C03 and thus neutralizes W (i.e. , H+ + HC03- B H2C03) (Aickin, 1984; for review 
see Chipperfield and Harper, 2000). 
1.5.2. Role ojCr 
There is both physiological and pharmacological evidence in support of the view that 
, 
Ca2+ -dependent Cl currents play a pivotal role in influencing changes in membrane 
potential in vascular smooth muscle cells (for reviews see Large and Wang, 1996; 
Kitamura and YamazaJ<.i, 2001). There is now ample evidence to suggest that agonist-
induced stimulation of a-adrenoceptors causes a release of Ca2+ from intracellular stores, 
probably the sarcoplasmic reticulum (Byrne and Large, 1988; KlOckner, 1993). 
Consequently, the rise in intracellular Ca2+ leads to the opening of Ca2+ -dependent Cl 
channels (Amedee eta!., 1990; Baronet al., 1991). The resulting change in Cl 
conductance produces membrane depolarization, which leads to the opening of voltage-
dependent Ca channels (Van Heiden, 1988). Opening of voltage-dependent Ca channels 
leads to Ca2+ influx, which is a key factor in the process involving contractions in blood 
vessels (Criddle eta!., 1996; Lum Min et al. , 1999). 
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1.5.3. Cl channel antagonists 
Ca2+ -activated Cl channels are believed to be widely distributed in vascular smooth 
muscle cells and are involved in important physiological processes such as agonist-
induced depolarization (for review see Large and Wang, 1996). A number of studies 
have revealed that selective antagonism of Ca2+ -dependent Cl channels results in 
inhibition of adrenoceptor-mediated contractions in functioning blood vessels (Baron et 
al. , 1991; Criddle et al. , 1996, 1997). To assess the physiological role ofCa2+-dependent 
Cl channels in vascular smooth muscle cells, Criddle et al. (1996) examined the effects of 
niflumic acid on both K+- and agonist-induced contractions. They showed that niflumic 
I 
acid (1-30 f..I.M) selectively inhibited the agonist-induced contraction without changing the 
high K+-induced contraction in both the rat aorta and rat mesenteric artery (Criddle et al., 
1996, 1997). Evidence in the literature appears to indicate that niflumic acid is capable of 
selectively inhibiting Ca2+ -dependent Cl channels by blocking the open state of Cl 
channels (Hogg et al., 1994). In addition, niflumic acid has been found to antagonize a 1-
adrenoceptor-mediated vasoconstriction in isolated perfused mesenteric blood vessels (He 
and Tabrizchi, 1997; Remillard eta/., 2000). Taken together, it can be suggested that 
niflumic acid appears to be the most potent and selective inhibitor of Ca2+ -dependent Cl 
channels (Greenwood and Large, 1995; for review see Large and Wang, 1996). 
A comparative study was conducted recently on the effects of Cl channel blockers on 
mesenteric vascular conductance in anesthetized rats (Parai and Tabrizchi, 2002). The 
effects of three putative Cl channel blockers, niflumic acid, indanyloxyacetic acid 94 
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(IAA-94) and diphenylamine -2- carboxylic acid (DPC), on cirazoline-mediated 
vasoconstriction in mesenteric blood vessel was examined in vivo. The arterial blood 
pressure, heart rate, and mesenteric blood flow was measured in anesthetized rats. 
Infusion of a 1-adrenoceptor agonist, cirazoline produced a dose-dependent increase in 
arterial blood pressure, and a decrease in heart rate, superior mesenteric blood flow, and 
mesenteric vascular conductance. It was observed that niflumic acid and IAA-94 did not 
have any impact on cira-zoline-induced changes in blood pressure, whereas DPC 
accentuated the pressor effect of cirazoline. Neither agent affected cirazoline-mediated 
reflex reduction in heart rate. In addition, niflumic acid and DPC were found to be most 
f 
effective in attenuating a 1-adrenoceptor mediated decreases in mesenteric blood flow and 
mesenteric vascular conductance, whereas IAA-94 had a negligible effect. Based on the 
profile of the actions of these compounds, it was suggested that IAA-94 did not appear to 
act as a selective inhibitor of Ca2+ -activated Cl channels when compared to niflumic acid 
in the mesenteric blood vessels. In addition, while DPC seems to be as effective as 
niflumic acid in its effects on mesenteric blood vessels, its actions may be attributed to 
other pharmacological effects (Parai and Tabrizchi, 2002). Taken together, it would 
appear that niflumic acid is capable of inhibiting receptor-mediated contraction in blood 
vessels by affecting Ca2+-dependent Cl channels (Greenwood and Large, 1995; Criddle ~t 
al. , 1996; He and Tabrizchi, 1997; Parai and Tabrizchi, 2002). 
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1.5.4. cr and endothelial cells 
In blood vessels there seems to be an interesting relationship between cr and endothelial 
cells. A report by Lamb and Barna (1998a,b) has suggested that the endothelium may 
regulate vascular tone via an effect on vascular smooth muscle Cl channels. These 
studies have demonstrated that noradrenaline-induced contractions of rat aorta from 
normotensive rats were potentiated in low Cl- buffer (Lamb and Barna, 1998a,b ). In 
addition, it was suggested that the magnitude ofthis potentiation is dependent on 
endothelial nitric oxide (Lamb and Barna, 1998b ). Therefore they had concluded that 
nitric oxide could inhibit the opening of voltage-dependent Ca channels by an agonist. 
This inhibition may be direct (via cGMP inhibition) or indirect (by preventing the 
activation of depolarizing Cl currents) (Lamb and Barna, 1998b ). In another study, 
Tabrizchi and Dugg~ (2000) have also supported a close link between Cl- handling and 
endothelial cell function in blood vessels (Tabrizchi and Duggan, 2000). Thus, the 
relationship between the role of cr and endothelial cells needs to be developed better. 
1.6. Nitric Oxide 
Furchgott and Zawadzki (1980) first recognized the fundamental importance of 
endothelial cells in the control of vascular tone. They found that the addition of 
acetylcholine to rabbit intact aortic strips, contracted with noradrenaline, caused 
concentration-dependent relaxation, but had little effect in those in which the endothelial 
cells had been removed (Furchgott and Zawadzki, 1980). Since the relaxation to 
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acetylcholine was also obtained in a helical strip without endothelium following its close 
apposition to an intact strip with endothelial cells, they concluded that endothelial cells 
release a labile factor that causes blood vessels to dilate (Furchgott and Zawadzki, 1980). 
This factor was termed endothelium-derived relaxing factor and has since been identified 
as nitric oxide (NO) (Palmer et al. , 1987). Endogenous NO is enzymatically produced by 
the conversion of the amino acid L-arginine to L-citrulline, a reaction catalyzed by the 
enzyme NO synthase (NOS) (Palmer et al. , 1988). This reaction also requires cofactors 
such as molecular oxygen, nicotinamide adenine dinucleotide phosphate, flavin adenine 
dinucleotide, heme, flavin adenine mononucleotide, calmodulin and tetrahydrobiopterin 
I 
for optimal function (Palmer et al. , 1987; Moncada and Higgs, 1993). NOS belong to a 
family of oxidoreductases that bear close sequence homology to cytochrome P450 
enzymes. Three different NOS isoforms have been cloned and characterized: endothelial 
NOS (eNOS) (Forstermann et al., 1991), inducible NOS (iNOS) (Hevel et al. , 1991), and 
neuronal NOS (nNOS) (Bredt et al. , 1991). In the endothelial cell, eNOS is activated by 
a number of agonists acting on G-protein-coupled receptors and by physical stimuli such 
as shear stress (for review see Schini-Kerth and V anhoutte, 1995). The physiology and 
pharmacology ofNO have been greatly aided by the availability of potent and apparently 
selective inhibitors of NOS, the most commonly used being the substrate analogues of L-
arginine (for review see Andrews et al. , 2002). For example, Nro -monomethyl-L-arginine 
(L-NMMA), N<'l-nitro-L-arginine (L-NNA), Nro nitro-L-arginine methyl ester (L-NAME) 
(for review see Andrews et al. , 2002). 
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1.6.1. Chemistry of NO 
NO is a paramagnetic and a free radical species, since it carries a single unpaired electron 
on its outer shell (in total 11 electrons) (for review see Andrews et al., 2002). The 
solubility of N 0 in water is quite low -1.9 x 10-3 M at 25°C (F eelisch, 1991 ). Due to its 
low water solubility, it can diffuse rapidly across the phospholipid membranes into the 
adjacent smooth muscle cells. The half-life ofNO under bioassay conditions have been 
reported to be 3-5 sec (for review see Moncada et al., 1989; Feelisch, 1991). NO reacts 
with oxygen and produces various free radicals such as nitrite, nitrate, nitroxyl, 
nitrosonium, peroxynitrite (Beckman et al., 1990). Peroxynitrite oxidizes protein, DNA 
I 
and lipids and consequently, may be cytotoxic to potential pathogens. The biological 
actions of NO are terminated when they react with the scavenger molecules such as 
hydroquinone, circulating oxyhemoglobin (HbO), and hydroxycobalamin. HbO reacts 
with NO to form the complex nitrosylHbO, which is then oxidized to metHbO and N0-3 
(Ignarro et al., 1993). Hydroxycobalamin also has a high affinity for NO, which it 
combines to form nitrosocobalamin (Rajanayagam et al., 1993). Thus due to the unique 
chemistry of NO it can react with many different cellular constituents. 
1. 6. 2. Mechanisms of NO action 
NO plays an important role in the regulation of myocardial contractility, platelet 
aggregation, vascular tone, and cytostasis. Although NO appears to be the major 
vasodilator released by endothelial cells in a vast majority of blood vessels, other 
substances, such as prostacyclin and the endothelium-derived hyperpolarizing factors also 
play a role (for review see McGuire eta!., 2001 ). These endothelial factors, and 
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particularly NO, are also involved in other regulatory functions such as inhibition of 
leucocyte, monocyte and platelet adhesion, vascular smooth muscle proliferation, 
vascular permeability and inflammatory mechanisms (for review see Boulanger, 1999). 
Thus they contribute to the protective role of the endothelium. Moncada et al. (1991) had 
proposed "the cardiovascular system is in a constant state of active vasodilation 
dependent on the generation ofNO". This statement represents the importance of NO in 
endothelium-dependent vasodilator mechanisms. It has also been suggested that NO can 
directly activate ci+-dependent K channels and voltage-gated K channels leading to 
endotheli urn -dependent hyperpolarization of vascular smooth muscle cells (Bolotina et 
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al. , 1994; Yuan et al. , 1996). NO release activates soluble guanylyl cyclase in smooth 
muscle cells, platelets, neurons and other cells and thereby increasing the levels of 
intracellular messenger cGMP (Katsuki et al. , 1977; Murphy and Walker, 1998). 
Elevation of cGMP, which is often transient and varies with tissue type is believed to 
activate the enzyme PKG (for review see Lincoln and Cornwell, 1993), which is 
correlated with relaxation by an undefined mechanism. Proposed sites of action include 
(i) reduction of myoplasmic Ca2+, (ii) alteration of Ca2+ sensitivity of phosphorylation, 
and/or (iii) alternative phosphorylation of other contractile or cytoskeletal proteins 
(Draznin et al. , 1986). Cell suspensions from rabbit or pig coronary arteries treated with 
acetylcholine followed by nitroglycerin demonstrated increased Ca2+ efflux (Itoh et al. , 
1983). Twort and van Breemen (1988) demonstrated increase uptake of Ca2+ into cellular 
stores in saponin-skinned cultured rat aortic cells treated with cGMP. Chen and Rembold 
(1992) demonstrated decreased Ca2+ influx in the intact swine carotid artery in agonist-
stimulated preparations treated with nitroglycerin. Therefore, NO/cGMP-mediated 
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pathway can cause a reduction in intracellular Ca2+ concentration which could be 
produced through decreased Ca2+ influx, increased efflux or increased uptake into the 
intracellular stores (for review see McDaniel et al. , 1994). Thus, the belief that NO could 
be a mediator that initiated relaxation via the generation of cGMP was born. 
Furthermore, evidence suggests that eNOS and nNOS are Ca2+/calmodulin-dependent 
enzymes and they produce NO in low concentrations (nM) for physiological purposes 
such as relaxation of smooth muscle (for review see Albrecht et al., 2003 ). In contrast, 
expression of iN OS results in the production NO in high concentration (1-!M) (for ,review 
see Albrecht et al. , 2003). The eNOS is the major NOS isoform expressed in the 
cardiovascular system mainly in vascular endothelium and plays an important role in 
regulation of vascular tone (for review see Mungrue et al., 2003). To investigate the role 
of different NOS enzymes, NOS knockout ( - /-) mice have been utilized. Huang et al. 
(1995) first demonstrated that the absence of eNOS led to a decrease in acetylcholine-
dependent relaxation in intact aortic rings from eNOS-/- mice, and that these mice were 
hypertensive, supporting a role for eNOS derived NO in the regulation of blood pressure. 
Most studies have shown that eNOS-/- mice have higher blood pressure than wild-type 
mice, although the magnitude of hypertension reported by different laboratories varies 
(Kurihara et al. , 1998; Stauss et al. , 1999; Van Vliet et al., 2003). In addition, eNOS-/-
mice were subsequently shown to have age-dependent left ventricular hypertrophy 
associated with hypertension (Barouch et al. , 2002). This evidence certainly supports a 
role for NO, generated primarily from eNOS, in the regulation of vascular tone, and 
consequently blood pressure homeostasis and tissue perfusion. However, it is clear that 
the magnitude of the role ofNO in the development of hypertension remains to be 
determined. 
1.7. Hypertension 
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Hypertension is a state in which the systemic arterial pressure is inappropriately elevated. 
This is a prevalent cardiovascular condition in Westernized communities, and is a major 
risk factor for stroke, coronary heart disease, and heart failure (Chobanian et al. , 2003). 
In almost 95% of the affected patients, the cause of the blood pressure elevation is 
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unknown and the condition is classified as primary or essential hypertension. High blood 
pressure attributed to a definable cause is termed secondary hypertension. The blood 
pressure is classified based on the mean of two or more properly measured blood pressure 
readings obtained in the seated position during two or more office visits. The severity of 
hypertension is classified on the basis of the systolic and/or diastolic blood pressures 
measured (see Table 3, Chobanian et al. , 2003). 
A simple definition of blood pressure (BP) based on hemodynamic parameters ofthe 
circuit is equal to the product of cardiac output (CO) and total peripheral vascular 
resistance (TPR) (Deshmukh et al. , 1998). 
i.e. , BP =CO x TPR 
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Table 3 
Blood pressure classification* based on systolic and diastolic pressure. 
BP classification Systolic BP, mmHg Diastolic BP, mmHg 
Normal < 120 and < 80 
Prehypertension 120- 139 or 80-89 
Stage 1 hypertension 140-159 or 90-99 
Stage 2 hypertension ?:: 160 or ?:: 100 
*According to the US Joint National Committee report VII. 
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In sustained hypertension, CO is usually normal and the increase in BP can usually be 
attributed to increase in TPR. The determinants of BP are multifactorial and the 
relationship ofBP =COx TPR is used to provide a standardized comparison under 
different conditions. Abnormalities in the structure and function of the vasculatures are 
recognized as factors contributing to the hypertensive state that increase total peripheral 
resistance. Increased peripheral resistance in experimental hypertension is the result of an 
imbalance between vasoconstriction and vasorelaxation. Structural adaptation of the 
cardiovascular system such as blood vessel narrowing and wall thickening associated 
with hypercontractility also plays an important role in increasing peripheral resistance to 
flow (for review see Folkow, 1982). 
I. 7. I. Structural and functional changes associated with hypertension 
Changes in vascular architecture also play an important role in modifying blood vessel 
function during hypertension. Lee and Smeda (1985) have suggested that morphological 
changes in muscular arteries can be primarily involved in the initiation of hypertension. 
Other studies have also shown that the remodeling of large and small arteries contributes 
to the development and complications of hypertension (for review see Intengan and 
Schiffrin, 2001). Remodeling can be either hypertrophic or eutrophic in nature (for 
review see Zervoudaki and Toutouzas, 2003). Hypertrophic remodeling is associated 
with a same or smaller lumen, increased wall mass, and an increase in wall to lumen ratio. 
Eutrophic remodeling is characterized by a smaller lumen, same wall mass, and an 
increase in wall to lumen ratio (for review see Zervoudaki and Toutouzas, 2003). Two 
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important parameters for the study of vessel remodeling are the "wall thickness/lumen 
diameter" ratio and the cross-sectional wall area (for review see Mulvany, 1984). The 
calculation of the "media thickness/lumen diameter" ratio, according to Laplace's law, 
provides information about the ability of the vessels to contract against intravascular 
pressure (for review see Zervoudaki and Toutouzas, 2003). The knowledge of wall cross-
sectional area indicates the amount of material within the vascular wall and thus provides 
information about the p:mcess of growth or regression. Collectively, it seems that 
morphological changes can contribute to greater resistance to flow, which by extension 
can manifest as high systemic pressure. 
Folkow and his colleagues (1973, 1982) have also suggested that structural changes lead 
to a fixed hyperresponsiveness of the arterial vascular system and cause sustained 
hypertension. They have suggested that in some forms of essential hypertension the 
elevated resting tone of the blood vessel could be explained entirely by structural 
modification of the vessel (Folkow et al. , 1970; Folkow, 1982). Finch and Hauesler 
( 197 4) using a variety of perfused preparations showed that while the responsiveness to 
noradrenaline was elevated in hypertension, the response to Ca2+ in depolarized 
mesenteric artery preparations was not altered. Hamilton (1975) has demonstrated that 
the change in perfusion pressure produced by noradrenaline differed both quantitatively 
and qualitatively from that produced by serotonin in perfused mesenteric bed from 
spontaneously hypertensive rats. Likewise, Lokhandwala and Eikenburg (1983) 
demonstrated differential sensitivity changes to noradrenaline, vasopressin and barium 
chloride in isolated perfused mesenteric bed from spontaneously hypertensive rats. These 
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studies point out that while structural adaptation could explain some of the characteristics 
of dose-response curves in perfusion studies from hypertensive rats, the magnitude of 
contractions differs depending on the agonist used. These difference in sensitivity would 
be intrinsic to the properties of the vessels from hypertensive animals. 
In general, vasoconstrictor drugs are reported to show a greater potency in blood vessels 
from hypertensive subjects or animals compared with those from matched normotensive 
controls (McGregor and Smirk, 1968; 1970; Luscher et al., 1987). It has been 
demonstrated that noradrenaline, angiotensin, and 5-hydroxytryptamine caused a greater 
degree of vasoconstriction in isolated perfused mesenteric arteries in rats with 
experimental renal hypertension than in the normotensive controls (McGregor and Smirk, 
1968, 1970). Also endothelium-dependent relaxations are reported to be impaired in 
arteries from spontaneously hypertensive rats (Konishi and Su, 1983 ). Alteration in the 
biochemical signaling pathways have been reported at almost every step in the 
transduction of agonist-induced contractile activity. Increased activation of PLC has been 
shown to be responsible for increased accumulation of the second messengers IP3 and 
DAG in amtas in spontaneously hypertensive rat (Kato et al., 1992). 
1. 7.2. NO and hypertension 
As NO became recognized as an important endothelial mediator of relaxation, studies 
investigated the relationship between high blood pressure and altered endothelial 
function. During the development of hypertension, the balance between the production of 
endothelial vasoconstrictor and vasodilator compounds is altered (for review see Luscher, 
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1990). A study conducted by Rees eta!. (1989) demonstrated that the L-arginine 
analogue, L-NMMA (which inhibits endothelial NO formation) increased blood pressure 
in a dose-dependent manner in anesthetized rabbits. Furthermore, L-NMMA was found 
to produce hypertension in animals indicating the potential possibility that endothelial NO 
participated in arterial blood pressure regulation (Moncada eta!., 1991). In aorta and 
mesenteric resistance arteries of spontaneously hypertensive rats, L-NMMA itself 
produces very little contraction but enhances the contraction produced by noradrenaline 
to a greater extent in Wistar-Kyoto rats versus spontaneously hypertensive rats (Dohi et 
a!., 1990). Tschudi et al. ( 1996) demonstrated that during hypertension rat mesenteric 
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arteries exhibit an increase in NO metabolism, and unaltered NO release. African-
Americans who are more susceptible to high blood pressure development demonstrate 
both endothelial dysfunction and increased renal vasoconstriction in response to salt 
loading (Cardillo et al., 1999). Evidence suggest that L-arginine supplementation can 
lower blood pressure in humans (Nakaki et al., 1990; Siani eta!., 2000). Taken together, 
both experimental and clinical evidence supports the view that the alteration ofNO 
release can play a role in hypertension development. 
I . 7.3. Animal models of hypertension 
The predominant form of hypertension (essential/primary) in humans is of an unknown 
etiology. Inbreeding of animals with naturally occurring high blood pressure has led to 
the production of several strains of hypertensive rats that are thought to represent models 
of essential hypertension in humans. Sir Horace Smirk first conceived the idea of 
selectively breeding rats for hypertension and developed the New Zealand strain of 
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genetically hypertensive rats (Smirk and Hall, 1958; Phelan et al., 1976). This was 
followed by the development of other strains such as the Wistar-Kyoto spontaneously 
hypertensive rat (Okamoto and Aoki, 1963; Yamori and Okamoto, 1976), the Dahl salt-
sensitive rats (Dahl et al., 1962), the Milan strain (Bianchi and Baer, 1976) and the 
Brunus Edwardii strain (Blackmore et al., 1972) which demonstrated inherited 
hypertension associated with unknown etiology. 
1. 7. 4. Clinical hypertension 
While the etiology of primary hypertension is unclear, it is supposed that the cause is 
multifactorial in nature involving genetic, dietary, and environmental factors. In terms of 
dietary causes, salt consumption can promote the development of high blood pressure. 
Many hypertensive individuals are considered to be "salt-sensitive" in that their blood 
pressure is increased by a high NaCl intake and reduced by dietary salt restriction (Dahl, 
1972). Depending on the exact definition of salt sensitivity, 30%-50% of all patients with 
essential hypertension may be salt sensitive, with this figure approaching 75% in African-
Americans (Weinberger, 1996). Since hypertension is maintained by a high peripheral 
resistance to flow during established phase, one goal of hypertension research has been to 
define the mechanisms responsible for the development and maintenance of this increased 
resistance. From a physiological standpoint, it is equally important to understand the 
effect of a sustained increase in vascular resistance on local blood flow and organ 
function. Since in vivo studies of vasculature resistance and local blood flow often 
require invasive techniques, most of the information in this subject area has been obtained 
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from the use of animal hypertensive models as opposed to human hypertensive subjects. 
One such interesting model is the Dahl salt-resistant and salt-sensitive rat. 
1.8. Dahl Rats 
I . 8.1 . Historical background 
Effects of a high salt die.t on the blood pressure of rat have been studied since the 1950s. 
Meeneely and Ball (1958) showed that the average blood pressure in rats was positively 
and linearly related to the dietary NaCl (between 0 and 10% NaCl). In the early 1960s 
Dr. Lewis K. Dahl showed that chronic excess salt ingestion produced sustained 
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hypertension in some rats (Dahl, 1961 ). Depending on the observation that not all rats 
responded to salt with similar changes in blood pressure, Dahl et al. (1962) were able to 
selectively breed Sprague-Dawley rats that were susceptibile (DS rats) or resistant (DR 
rats) to hypertension development in response to a 8% NaCl diet. This work was carried 
out on a colony of Sprague-Dawley rats that was presumably maintained by breeding at 
Brookhaven Laboratory. After three generations of selective breeding, the DS and DR 
lines were clearly separated. The blood pressures of DR rats were normal and similar on 
control or high salt diets, but DS rats responded to salt with a pronounced increase in 
blood pressure (Dahl et al. , 1962). Thus, the two strains yielded an interesting model that 
could be used to assess the interaction of a dietary factor (salt) with genotype. Blood 
pressure is a polygenic trait, which means that there are multiple genetic loci with effects 
on blood pressure. Using quantitative genetic techniques it was estimated that 
approximately 2-4 genetic loci were involved in controlling the blood pressure response 
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to salt in DS and DR rats (Knudsen eta!., 1970). Recently it had been suggested that 
chromosomes 3,6,7,11 are important in regulating arterial pressure and renal function in 
female DS rats (Moreno eta!., 2003) whereas chromosomes 1,3,19 are responsible for 
cardiac hypertrophy in DS rats (Siegel et al. , 2003 ). The extreme sensitivity of the DS rat 
to the salt is a unique trait and the extreme resistance of the DR rat is equally unique (for 
review see Rapp, 1982). 
1.8.2. General characteristics of the strains 
DS rats placed on a high salt (8% NaCl) diet at weaning (21-23 days of age) rapidly 
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develop hypertension and all die after 16 weeks of salt feeding, whereas DR rats fed the 
same diet maintain blood pressure in the normotensive range, and 80% of the animals 
survive after 48 weeks of high salt feeding (Knudsen eta!., 1970). There was no marked 
retention ofNa+ in DS versus DR rats as measured by whole carcass Na+, or half-life of 
22Na. There was also no depletion of carcass K+ in DS rats (Schackow and Dahl, 1966). 
Electron-probe analysis of intracellular Na +, K+, and Cl- concentrations indicated similar 
levels for DS and DR rats on low- and high-salt diets (Abel et a!. , 1981 ). The mechanism 
of salt-induced hypertension in Dahl salt-sensitive rats involves neural, humoral and renal 
pathways (for review see Rapp, 1982). 
1. 8. 3. Neural mechanisms in Dahl rats 
An early increase in sympathetic nerve activity in salt-induced hypertension has been 
implicated as an important factor in its pathogenesis (Mark, 1991). Using 6-
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hydroxydopamine to induce chemical sympathectomy, Takeshita et al. (1979) were able 
to show that an intact sympathetic nervous system was essential for the development of 
salt-induced hypertension and increased vascular resistance in the hindquarters of 
hypertensive DS rats. Increased sympathetic nerve activity in the heart and kidney ofDS 
hypertensive rats was associated with increased noradrenaline turnover (Peular et al., 
1989). Surprisingly, this state was usually accompanied by reduced tissue noradrenaline 
content, reflecting higher noradrenaline utilization in the respective organs (Racz et al., 
1987). Using histochemical fluorescent technique, Kunes et al. (1991) have shown that a 
chronic elevation of salt intake reduced the density of visible adrenergic plexus as well as 
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the intensity of catecholamine fluorescence in terminal axons of mesenteric and renal 
vascular beds in salt hypertensive Dahl rats. They suggested that a reduction of 
noradrenaline uptake and noradrenaline content might be the result of a less dense 
adrenergic innervation of mesenteric blood vessels in DS rats (Kunes et al., 1991 ). 
Bayorh et al. (1998) have reported fourfold increase in plasma arginine-vasopressin, 
which in turn activates sympathetic nervous system and vascular responses. Altogether it 
seems that a hyperactive sympathetic nervous system may contribute in maintaining a 
hypertensive state in salt hypertensive Dahl rats. 
Furthermore, DR rats show more exploratory behavior and greater aggressive behavior 
than DS rats (Welner eta!., 1968; Ben-I shay and Welner, 1969). The relationship of this 
behavior to blood pressure is obscure, and the difference could have arisen from genetic 
drift, i.e., chance selection of behavior pattern. 
49 
1.8.4. Renal mechanisms in Dahl rats 
There is a considerable amount of evidence to indicate a primary defect in renal function 
in DS rats as a cause of hypertension. Tobian et al. (1966) were the first to show that a 
genetic fault in the kidneys of the DS rat potentially caused hypertension. This work was 
confirmed later by Dahl et al. (1972, 1974) where they found that when kidneys are 
transplanted from one strain to the other, the influence on blood pressure arrives with the 
kidney. Therefore, a kiclney from DS rat when transplanted into a DR rat elevates the 
blood pressure ofthe later and vice versa (Tobain et al., 1966; Dahl et al., 1972, 1974). 
These transplantation experiments suggested some type of baroreceptor resetting within 
, 
the kidneys, which by itself was able to regulate blood pressure. It has been reported that 
the DS rats have 15% fewer glomeruli than DR (Azar et al., 1978). Following 20-30 days 
of high salt to induce mild hypertension in the DS rats, the DS showed increased single 
nephron blood flow, increased single nephron glomerular filtration rate, and decreased 
resistance at the afferent and efferent arteriolar segments which might be the adaptive 
changes to the reduced number of glomeruli (Azar et al., 1979). 
1. 8. 5. Changes in blood vessel structure in Dahl hypertensive rats 
The elevation in blood pressure in salt hypertensive Dahl rats has been suggested to be 
associated with the development of structural alterations in blood vessels. Lee and 
Triggle ( 1986) did an extensive morphometric analysis of mesenteric arteries from DS 
hypertensive rats. Their results showed that the cross-sectional area of the media was 
increased in superior, large, and small mesenteric arteries from DS-high salt rats when 
compared to OS-low salt, DR-high salt, and DR-low salt groups. In the large muscular 
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arteries, the increase in the size of the vessel wall in hypertensive Dahl rats was produced 
by a widening of subendothelial space, hyperplasia of medial smooth muscle cells and the 
presence of a larger adventitial layer. In the small mesenteric arteries of hypertensive DS 
rats, the increase in size of the medial wall was probably due to hypertrophy of the 
smooth muscle cells and/or an increase in the extracellular space (Lee and Triggle, 1986). 
Mesenteric vessels have been noted to undergo medial wall thickening that positively 
correlates with the incre-ase in blood pressure during salt-induced hypertension (Lee and 
Triggle, 1986). Therefore, it is inferred that hyperactivity of the mesenteric arteries of 
Dahl hypertensive rats is either due to increased smooth muscle mass or impaired 
I 
endothelial cell function (Lee and Triggle, 1986). Increased media thickening has also 
been noted in carotid artery (Benetos et al. 1995), basilar artery (d'Uscio et al. 1997), and 
aorta (Duggan and Tabrizchi, 2002) of Dahl hypertensive rats. Intengan and Schiffrin 
( 1998) have argued that the morphological changes in mesenteric bed of Dahl salt-
sensitive hypertensive rats are due to eutrophic remodeling, and have further suggested 
that this could, in part, be responsible for hyperactivity of the blood vessels in this bed in 
such animals. 
1. 8. 6. Endothelial dysfunction in Dahl hypertensive rats 
During the past decade, it has become increasingly clear that the endothelium, the single 
innermost layer of blood vessels, is more than a passive barrier between the blood and the 
vascular smooth muscle (for review see Boulanger, 1999). We now know that the 
endothelium plays a crucial role in circulatory homeostasis responding not only to 
humoral and chemical signals, but also to changes in hemodynamics of blood flow such 
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as shear stress (for review see Fisher eta!. , 2001 ). LUscher eta!. ( 1987) have 
demonstrated that in DS rats, contractions in response to noradrenaline in aortic rings are 
increased while relaxations in response to acetylcholine are depressed. Evidence suggests 
that in hypertensive Dahl rats, administration of L-arginine reduces blood pressure and 
restores endothelium-dependent relaxations (Chen and Sanders, 1991; Patel eta!. , 1993 ). 
Nishida eta!. (1998) has suggested that the vascular hypercontractile responses to 
noradrenaline in DS hypertensive rats can, in part, be explained by impairment in 
endothelial NO production. Clearly, a popular hypothesis for the enhanced 
vasoconstriction seen in Dahl hypertensive rat is endothelial cell dysfunction (Nishida et 
a!., 1998). Furthermore, vascular smooth muscle cells from salt-sensitive Dahl rats are 
characterized by a mutation of the coding region of the iNOS gene associatedwith 
decreased nitrite/nitrate formation (Chen et al. , 1998). In contrast, a study performed 
using various isolated smooth muscle preparations (thoracic aorta, tail artery, portal vein, 
anococcygeus, perfused mesenteric bed) from Dahl rats have demonstrated that the 
reactivity to noradrenaline, serotonin, and phenylephrine were similar in DS and DR rats 
(Laher and Triggle, 1984). Similar results have also been reported by other investigators 
who have reported absence of increased contractility in blood vessels from DS 
hypertensive rats on a salt diet (Abel et al. , 1981; Kong et al., 1995). Thus, it is 
recognized that while endothelium-derived NO may contribute to the overall regulation of 
arterial blood pressure by virtue of its ability to relax vascular smooth muscle, its place in 
vascular dysfunction and hypertension in the Dahl model is not yet fully established. 
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Based on the evidence summarized above, the Dahl rat seems to be a viable model for 
examining the underlying pathology in salt hypertension and assess the alterations in 
blood vessel function in a species where the environmental factor (i.e., salt) is responsible 
for the pathology and thus hypertension. 
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1.9. NATURE OF THE PROBLEM 
Alterations in the behavior of blood vessels in salt-induced hypertension manifest 
themselves in term of changes in morphological (Lee and Triggle, 1986; Intengan and 
Schiffrin, 1998), mechanical (Nishida et al., 1998; Tabrizchi and Duggan, 2000), and 
electrical (Fujii et al. , 1997) activity of smooth muscle cells, not necessarily in this 
specific order. 
The role of architectural change in maintenance of high blood pressure in salt 
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hypertension has been put forward by several investigators (Benetos et al., 1995; d'Uscio 
et al., 1997), although there is controversy over the type of changes that occur in blood 
vessels. While it has been suggested that blood vessels in Dahl salt-sensitive 
hypertensive (SSH) rats undergo increases in smooth muscle mass (Lee and Triggle, 
1986), others have argued that the morphological changes in mesenteric bed of Dahl SSH 
rats are due to eutrophic remodeling (Intengan and Schiffrin, 1998). 
There are also conflicting reports regarding alterations in functional and electrical 
responses in blood vessels in salt hypertension. For example, Abel et al. (1981) and 
Laher and Triggle ( 1984) have suggested unaltered functional properties of blood vessels, 
whereas Nishida et al. (1998) have suggested increased contractile responses to 
vasoconstrictors in blood vessels from Dahl SSH when compared to salt-resistant 
normotensive (SRN) rats. 
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In addition, some authors have suggested that the resting Em was depolarized (Fujii eta!., 
1997; Wellman et al. , 2001), whereas another report have shown no difference (Abel et 
al. , 1981) in resting Em in vascular smooth muscle cells from Dahl SSH compared to SRN 
rats. The evidence in the literature in the context of altered behavior in blood vessels in 
salt-induced hypertension is inconsistent. Indeed, it seems that the inter-relationship 
between morphological, functional, and/or electrical change in salt-induced hypertension 
needs further development and investigation. 
One aspect of change in blood vessel behavior from salt-induced hypertensive rat appears 
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to be due to an altered relationship between endothelial cells, smooth muscle and Cl-. 
Evidence from our laboratory has suggested that differences exist in vasoconstrictor 
responses to a 1-adrenoceptor agonists in blood vessels from Dahl SRN and SSH rats in 
Cr-free buffer (Tabrizchi and Duggan, 2000; Bieger et al., 2004). Tabrizchi and Duggan 
(2000) have demonstrated that the removal of Cl- augmented cirazoline-evoked 
contractions in aorta of Dahl SRN rats, whereas it depressed the contraction in Dahl SSH 
rats. In contrast, Cl- removal from pulmonary artery did not alter cirazoline-induced 
vasoconstriction in Dahl SRN rats, but it did attenuate the vasoconstriction elicited by 
cirazoline in SSH rats (Bieger eta!. , 2004 ). This suggests that there is divergence in the 
behavior of conduit versus low-pressure blood vessels even within the same species. 
Thus it was concluded that the paradoxical effect of Cl--free buffer on contractions 
produced by cirazoline in blood vessels from Dahl SRN versus SSH rat supports a close 
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link between Cl- handling and endothelial cell function in these blood vessels (Tabrizchi 
and Duggan, 2000; Bieger et al., 2004). 
It is also recognized that alteration in endothelial cell function is, in part, responsible for 
changes in functional behavior of blood vessels in the developed state of hypertension 
(for review see Boulanger, 1999). Indeed, Luscher et al. (1987) have demonstrated that 
endothelium-dependent.relaxations were significantly depressed in aorta from Dahl SSH 
rats. In addition, Nishida et al. (1998) had suggested that impairment of endothelial NO 
production is involved in the increased contractile response to noradrenaline in Dahl SSH 
rats. Evidence from our laboratory has revealed that basal levels of cGMP in blobd 
vessels of Dahl SRN are significantly higher than those of SSH rats (Tabrizchi and 
Duggan, 2000; Bieger et al., 2004). Furthermore, it has been suggested that 
administration of L-arginine reduces blood pressure and restores endothelium-dependent 
relaxations in Dahl hypertensive rats (Chen and Sanders, 1991 ). Duggan and Tabrizchi 
(2002) have further demonstrated that relaxations elicited by Ca channel antagonists were 
attenuated in presence ofL-NAME in aortic rings from Dahl SRN but not in SSH rats. 
Taken together, it seems that the signaling pathway between NO/NO synthase, Cl- and 
smooth muscle cells is altered in blood vessels of SSH rats (Nishida et al., 1998; Duggan 
and Tabrizchi, 2002; Bieger et al., 2004). 
Studies from our laboratory have suggested an alteration in Cl- handling and endothelial 
cells in conduit and low-pressure blood vessels in Dahl SSH rats (Tabrizchi and Duggan, 
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2000; Bieger et al. , 2004 ). Thus the working hypothesis for this investigation is that the 
role of Cl- in excitation-contraction coupling is altered in resistance blood vessels in salt-
induced hypertension, perhaps due to alteration in NO/NO synthase pathways. With 
respect to the latter hypothesis, the questions addressed in this investigation were: (1) Is 
there an alteration in Cl- handling in mesenteric blood vessels in salt hypertension?; and 
(2) Is the relationship between cr and NO altered in mesenteric blood vessels in salt-
induced hypertension? ' 
The primary objective of the investigation was: (a) to compare the actions of the 
vasoconstrictor, cirazoline, on blood pressure, heart rate, mesenteric blood flow, and 
mesenteric vascular conductance; (b) to determine the impact ofthe NO synthase 
inhibitor, L-NAME, on basal and cirazoline-stimulated vascular conductance; (c) to 
. 
examine the impact of the Cl channel antagonist, niflumic acid, on basal and cirazoline-
stimulated vascular conductance; and (d) to assess any interaction between the effects of 
L-NAME and niflumic acid on cirazoline-mediated changes in vascular conductance in 
anesthetized Dahl SRN and SSH rats. 
Cirazoline-induced vasoconstriction was expected to be increased (i.e., reactivity and 
sensitivity) as a consequence of hypertension in Dahl SSH when compared to SRN rats. 
The basis for the latter observation, if true, could be due to an altered NO/NO synthase 
cascade that occurs in Dahl SSH rats. Accordingly, L-NAME was expected not to have 
any effect on responses to cirazoline in blood vessels from SSH rats while potentiating 
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the responses in SRN rats. However, any difference in response in presence ofniflumic 
acid was expected to be absent following treatment of animals with L-NAME. 
The secondary objective was: (a) to determine the effect ofCl- removal on al-
adrenoceptor-mediated vasoconstriction in isolated mesenteric blood vessels; (b) to 
evaluate the influence ofCl- upon addition ofL-NAME on a 1-adrenoceptor-mediated 
vasoconstriction; and ( c )•to assess the response of niflumic acid in presence and absence 
of Cl- on a 1-adrenoceptor-mediated vasoconstriction in isolated perfused mesenteric 
blood vessels and compare the differences in response between Dahl SRN and SSH rats. 
Since Cl- removal has a divergent effect in blood vessels, it was anticipated that Cl-
removal would either ~ave an inhibitory or potentiating effect on cirazoline-mediated 
vasoconstriction. The role of Cl- was suggested to be altered in salt hypertension and 
therefore C1--free buffer was expected to have a greater effect in Dahl SRN when 
compared to SSH rats. L-NAME was expected to have a potentiating effect on blood 
vessels from SRN rats and this response was expected to be altered in Cl--free buffer. 
Furthermore, Cl--free buffer was predicted to nullify the inhibitory effect of niflumic 
acid. 
The tertiary objective of this study was: (a) to determine the influence of cirazoline on 
vascular smooth muscle cell resting Em in superior mesenteric artery; (b) to determine the 
influence of Cl- removal on vascular smooth muscle cell Em in superior mesenteric artery; 
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and (c) to determine the influence ofL-NAME on vascular smooth muscle cell Em in 
superior mesenteric artery and evaluate the differences in behavior in salt hypertensive 
Dahl rats. In addition, the morphology of primary mesenteric blood vessels was assessed 
in Dahl SRN and SSH rats on salt diet for 7 weeks. 
The resting Em in superior mesenteric artery in Dahl SSH rats was expected to be either 
depolarized or similar to SRN rats. Cirazoline was expected to cause a membrane 
depolarization in vascular smooth muscle cells from Dahl SRN and SSH rats. Cl-
removal was anticipated to change the resting Em to a greater degree in vascular smooth 
muscle cells from Dahl SRN when compared to SSH rats. L-NAME was expected to 
have a depolarizing effect in blood vessels from Dahl SRN but not in SSH rats. In 
addition, the blood vessels from Dahl SSH rats were likely to have undergone 
morphological changes. 
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2. METHODS 
2.1. 0. Preparation of animals 
Female Rapp/Dahl rats (salt-resistant and salt-sensitive) were housed (two per 
· cage) with 12 h light/dark cycles and given access to normal food (0.26% Na, 0.44% Cl; 
LabDiet 5POO ProLab, PMI Nutrition International, Brentwood, MO, U.S.A.) and tap 
water ad libitum. At 6-'J weeks of age, animals were placed on a Japanese style diet 
containing 4% NaCl (Zeigler Brothers, Gardners, PA, U.S.A.). The animals were on 4% 
salt diet for 7 weeks. After 7 weeks all the Dahl SRN rats were in good health. 15% of 
I 
the Dahl SSH rats fed the above diet died or exhibited significant weight loss after being 
placed on the diet for 7 weeks. These were excluded from the study and the remaining 
85% of the healthy Dahl SSH rats were sampled. 
2.1.1. Blood pressure and heart rate determination 
Following 7 weeks on a 4% salt diet, each rat was weighed. Then the rat was 
anesthetized with halothane (5% in 100% oxygen for induction and 1.25% in 100% 
oxygen for maintenance). Body temperature was maintained at 36 ± 1 °C using a heating 
lamp. A catheter (polyethylene tubing ID 0.58 mm, OD 0.965 mm) was inserted into the 
left femoral artery for direct measurement of arterial blood pressure. The catheters were 
filled with heparinized saline (25 IU mr1 in 0.9% NaCl). Arterial blood pressure was 
recorded with a pressure transducer (Model TNF-R, Ohmeda, WI, U.S.A.) connected to a 
polygraph (Model 7PlF, Grass Instruments Co., MA, U.S.A.). Heart rate was derived 
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from the upstroke ofthe arterial pulse pressure by a tachograph (Model 7P44D, Grass 
Instruments Co., MA, U.S.A.). Arterial blood pressure and heart rate were recorded for 
15 min. Thereafter, blood samples were taken randomly from some animals for plasma 
N02-/N03- and blood volume measurements. 
2.1. 2. Plasma N02 -IN03- measurements 
After recording blood pressure and heart rate, plasma samples for N02 -/N03-
measurements was taken (n = 10). N02-/N03- was only determined in rats where plasma 
and blood volume were not measured. The plasma concentration ofN02 -/N03- was 
measured using a method similar to that described by Schmidt et al. (1992). Samples of 
180 1-1-l of blood and 20 1-1-l of sodium citrate (stock concentration-! 0% sodium citrate in 
0.9% NaCl; final con<?entration-1% sodium citrate in blood sample) were obtained and 
centrifuged at 10,000 rpm for 5 min to separate the cells from plasma. The plasma layer 
was separated and stored. The N03- in plasma was enzymatically converted to N02-. 
Essentially, N03- was reduced by incubation for 15 min at 37°C in the presence of nitrate 
reductase (1 IU ml- 1) , NADPH (500 1-1-M) and FAD (50 J.!M). The unused NADPH, 
which interferes with the assay, was oxidized by lactate dehydrogenase (100 IU ml-1) and 
sodium pyruvate (100 mM) by incubation for 5 min at 37°C. The total N02-/N03- in the 
plasma was then assayed by addition of Griess reagent to each sample and the optical 
density (OD) at 540 nm (As4o) was measured. The total N02-/N03- concentration was 
calculated by comparison with the A540 of a standard solution ofNaN02 also converted to 
N02-. 
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2.1.3. Plasma and blood volume determination 
Blood samples for plasma and blood volumes measurement were taken randomly from 
different groups of rats (n = 22). Plasma volume and total blood volume were determined 
according tO Migita et al. ( 1997). A sample of 100 ~1 of blood was collected in two 
heparinized capillary tubes before and after the administration of Evans blue dye (EBD) 
(5 mg kg- 1) . The samples were centrifuged for 3 min to obtain hematocrit (Hct) values. 
A 50 ~1 sample of plasma was collected from the hematocrit tubes and diluted 1 :20 in 
distilled water. The absorbance was recorded using 4050 UV Nisible spectrophotometer 
I (LKB Biochrom, Cambridge, England) at 620 nm (A620) and corrected for the presence of 
hemoglobin at A 62o (blank), and for turbidity at A 740. Plasma volume (PL V) was 
determined as follows: 
Where C and Vi are the concentration and volume, respectively, ofEBD that was injected 
and Cp is the plasma concentration ofEBD. A plasma trapping factor (tp) of0.96 and a 
total body-to-venous hematocrit ratio (F cells) of 0. 74 were employed (Migita et al. 1997) 
to estimate total blood volume (TBV) using the equation: 
TBV = PLY / 1 - (Hct X tp x Fcells) 
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2.2. Study 1: Blood flow measurements 
2. 2. I. Surgical preparation 
Additional catheters (polyethylene tubing ID 0.58 mm, OD 0.965 mm) were inserted into 
the left and right femoral veins for administration of drugs. After recording arterial blood 
pressure and heart rate, the anesthetic was switched to thiobutabarbital and titrated up to 
50 mg kg- 1 intravenousl;y. The anesthetized animals were tracheotomized using a 14-
gauge x 1/2 inch needle. The abdominal cavity was opened through a ventral midline 
incision and the superior mesenteric artery was exposed and carefully dissected free of 
, 
connective tissue. A transonic flow probe (Model 1RB630, Transonic Systems, NY, 
U.S.A.) was placed on the mesenteric artery and blood flow was measured using a 
flowmeter (Model T106, Transonic Systems, NY, U.S.A.) and displayed on a Grass 
polygraph (Model 7P1F, Grass Instruments Co., MA, U.S.A.) (Tabrizchi and Pugsley, 
2000). Arterial blood pressure was recorded with a pressure transducer (Model TNF-R, 
Ohmeda, WI, U.S.A.) connected to a polygraph (Model 7P1F, Grass Instruments Co., 
MA, U.S.A.). Heart rate was derived from the upstroke of the arterial pulse pressure 
using a tachograph (Model 7P44D, Grass Instruments Co., MA, U.S.A.). Body 
temperature was maintained at 36 ± 1 °C using a heating lamp and monitored rectally by a 
mercury thermometer. After completion of surgery, each animal was allowed to stabilize 
for a period of 60 min while blood pressure, mesenteric blood flow and heart rate were 
continuously monitored prior to administration of vehicle and/or drugs. At the end of the 
experiment each animal was sacrificed and the heart and kidneys were removed. The 
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weights of the left and right kidneys, right ventricle and left ventricle + septum were 
taken. 
2. 2. 2. Experimental protocol 
Animals were randomly assigned to four groups (n = 6). Following a stabilization period 
of 60 min, each animal received a cumulative continuous infusion of cirazoline (0.4, 0.8, 
1.6 and 3.2 j..tg kg- 1 min~ 1 ), with each dose infused for a period of 5-7 min. After 
completion of the first cirazoline dose-response curve, each animal was allowed to 
recover for 60 min. This period was sufficient to allow blood pressure, heart rate and 
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mesenteric blood flow to return to baseline (He and Tabrizchi, 1997; Parai and Tabrizchi, 
2002). Animals in each group then received a single bolus injection of saline (0.9% 
NaCl) and vehicle (0.4 M NaHC03 in 5% glucose); saline (0.9% NaCl) and niflumic acid 
(10 mg kg- 1); L-NAME (0.3 mg kg- 1) and vehicle (0.4 M NaHC03 in 5% glucose) and L-
NAME (0.3 mg kg- 1) and niflumic acid (10 mg kg-1). A period of 15 min was allowed to 
elapse after the bolus injection of vehicle or drugs before the second cumulative 
cirazoline dose-response curve was constructed. 
2.3. Study 2: Perfused isolated mesenteric artery preparation 
2. 3.1. Tissue isolation technique 
The blood pressure and heart rate were recorded for 15 min before the mesenteric blood 
vessels were isolated. Under halothane anesthesia, the abdominal cavity was opened and 
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the pancreatico-duodenal, ileo-colic and colic branches of the superior mesenteric artery 
were tied (McGregor, 1965). The superior mesenteric artery was then carefully separated 
from surrounding tissues and cannulated through an incision at the confluence with the 
abdominal aorta. The intestine was severed from the mesentery by cutting close to the 
intestinal border of the mesentery (McGregor, 1965). The mesenteric artery and its 
branches were flushed with physiological salt solution, transferred to a warmed organ 
chamber and perfused and superfused with Krebs-bicarbonate (normal Krebs) buffer 
maintained at 3 7°C and gassed with 95% 0 2 - 5% C02. The Krebs-bicarbonate buffer 
was of the following composition (in mM): NaC1120, KC14.6, glucose 11, MgS04 1.2, 
CaC}z 2.5, KH2P04 1.2, NaHC03 12.5. The pH ofthe buffer, following saturation' with a 
95% 0 2 : 5% C02 gas mixture, was 7.4. All experiments were performed in both normal 
Krebs and/or chloride-free buffer of the following composition (in mM): sodium 
propionate (C2H2COONa) 120, potassium propionate (C2H2COOK) 4.6, glucose 11 , 
MgS04 1.2, calcium gluconate (Ca(C6H 11 0 7)2) 2.5, KH2P04 1.2, NaHC03 12.5. The 
mesenteric blood vessels were perfused at a constant rate of 5 ml min-1 using a Vera 
Varistaltic Pump Plus (Model 72315000, IL, USA). The perfusion pressure was 
measured by means of a pressure transducer (PD23ID, Gould Statham) and displayed on 
a Grass polygraph (Model 79D, Grass Instruments Co., MA, USA). The perfused blood 
vessels were allowed to stabilize for an hour before the start of each experiment. After 
the removal of the mesenteric bed, the heart and kidneys were also removed. The weights 
of the left and right kidneys, right ventricle and left ventricle + septum were taken. 
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2.3.2. Experimental protocols 
2.3.2 .1. Series I 
Following stabilization for an hour in normal Krebs buffer, the tissues were initially 
exposed to a submaximal dose of cirazoline ( 10 nmoles) and then allowed to equilibrate 
for an additional hour. A control cirazoline dose-response curve (0.1 - 30 nmoles) was 
constructed in absence of vehicle or drugs. Perfusion pressure was allowed to return to 
baseline before the bolu9 injection of each dose of agonist was made. In three separate 
groups (n = 6) the effects of vehicle (0.4 M NaHC03 in 5% glucose; 10 J.!l 100 ml-1) , L-
NAME (10 11M), or niflumic acid (10 11M) were examined. Blood vessels were allowed 
, 
to stabilize for 30 min after the control dose-response curve and then perfused with buffer 
containing vehicle, L-NAME, or niflumic acid for 20 min prior to the construction of the 
second cirazoline dose-response curve. 
2.3.2.2. Series II 
In three separate groups (n = 6), the effects of vehicle, L-NAME, or niflumic acid were 
examined in Cl- -free buffer. A control cirazoline dose-response curve was obtained from 
mesenteric arteries perfused with normal Krebs as previously described. The tissues were 
then allowed to stabilize for 20 min while perfused with normal Krebs solution. The 
solution was then changed to cr-free buffer and after 10 min either vehicle (0.4 M 
NaHC03 in 5% glucose; 10 111100 ml- 1) , L-NAME (10 J.!M), or niflumic acid (10 11M) 
was added to the Cl--free buffer and 20 min was allowed to elapse before the second 
cirazoline dose-response curve was constructed. 
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2.4. Study 3: Electrophysiological Measurements 
Blood vessels from three different groups (n = 5 - 6) of rats were used for membrane 
potential measurements. After recording the blood pressure and heart rate under 
halothane anesthesia, the superior mesenteric artery was isolated and removed. Arterial 
rings were held in place,in a 5 ml sylgard lined tissue chamber superfused with 
physiological salt solution pre gassed with a mixture of 95% 02 : 5% C02 delivered at a 
rate of2-3 ml per minute and warmed to 35-36°C. Blood vessels were allowed to 
I 
equilibrate for 60 minutes, and the membrane potential was recorded with borosilicate 
capillary microelectrodes filled with KCl (3 .0 M) with a tip resistance of 10-15 MQ. The 
Ag/AgCl reference half-cell containing KCl (3.0 M) was connected to the bath via an 
agar salt bridge containing 150 mM NaCl. Impalements were made by means of a 
Narishige x-y-z micropositioner, typically from the endothelial side at depths> 30 J.lm 
below the surface. Criteria for impalement and measurement of smooth muscle cell 
membrane potential were an abrupt drop in voltage upon penetration of the cell 
membrane, a stable membrane potential for at least 1 minute, and a sharp return of the 
membrane potential to zero upon withdrawal of the electrode from the cell. Voltage 
signals were recorded by means of Axoclamp-2A (Axon Instruments Inc., CA, USA), the 
output of which was fed into a DigiData 1200 Series Interface (Axon Instruments Inc., 
CA, USA). Data were acquired and displayed on AxoScope (Version 1.1) and stored on a 
microcomputer (Bieger et al., 2004). 
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2. 4.1. Experimental protocols 
Membrane potentials from 5-6 cells were initially recorded prior to exposure of the blood 
vessels to drugs or cr-free buffer. Subsequently, tissues were exposed for 20-30 
minutes to solutions containing cirazoline (3 JlM) followed by normal Krebs; or cr-free 
buffer followed by Cl--free and cirazoline (3 JlM); or L-NAME (10 JlM) followed by L-
NAME (10 JlM) and cirazoline (3 JlM), and cells were then sampled for membrane 
potential measurements. Membrane potential recordings were carried out by sampling 
5-7 cells individually after the addition of drug or cr-free solution. A junction potential 
, 
of 4-5 mV was noted in Cl--free buffer when pipettes were kept extracellularly during the 
switch from Cl- containing to cr-free medium and this was corrected. 
2.5. Study 4: Morphometric Measurements 
Prior to removal of superior mes~nteric artery, a segment of primary mesenteric artery 
and vein (3- 4 mm in length) from Dahl SRN and SSH rats (n = 22) was isolated and 
placed in 4% paraformaldehyde in 0.1 M phosphate buffer solution for 24 hr before 
processing for routine histology. The processing of the blood vessels was done overnight 
where tissues were exposed to a series of solutions of buffered formalin, ethanol, xylene, 
and surgipath blue paraffin bath using Tissue-Tek V.I.P. vacuum infiltration process 
(Sakura Finietek USA, Inc. , 300 E, Torrance, CA, USA). Each tissue was then sectioned 
at 8 J.lm by a microtome, and mounted on positive charged slides. The tissues were 
68 
finally stained with Weigert's iron hematoxylin and van Gieson's dyes (Luna, 1968). 
Four to six sections ofthe arterial and venous rings from each rat were then examined and 
morphometric measurements were made of perimeter, lumen area, smooth muscle 
thickness, and lumen diameter using Neurolucide software (Micro Brightfield Inc., 
Vermount, USA) with a Microvid microscope Leitz Diaplan, (Model 020-437.035, Ernst 
Leitz Wetzlar GMBH, Germany) (Mong et al., 2002). 
2.6. Drugs and Reagents 
All the reagents and drugs were purchased from Sigma (Oakville, Ontario, Canada). 
Cirazoline hydrochloride ( (2-[ (2-cyclopropylphenoxy)methyl]-4,5 -dihydro-1 H-
imidazole); C13H 16N20.HC1), and L-NAME (Nw nitro-L-arginine methyl ester; 
C7H1sNs04.HCl) were dissolved in saline (for in vivo experiments) or distilled water (for 
in vitro experiments). Niflumic acid (C 13H9F3N20 2) was dissolved in 0.4 M NaHC03 in 
5% glucose solution. The structures of cirazoline, niflumic acid, and L-NAME are 
represented in Figure 2. 
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Niflurnic Acid 
NH 
II . H 
02NHN-C-N-C-C-C-C-NH2 
H H2 H2 H2 I L-NAME 
C02CH3 
Figure 2. Chemical structure of cirazoline, niflumic acid, and L-NAME. 
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2.7. Data and Statistical Analysis 
Mesenteric blood flow was corrected for body weight in each group of rats (blood 
flow/body weight x 1 00). Vascular conductance was calculated as flow divided by mean 
arterial blood pressure. Mean arterial blood pressure was approximated as diastolic blood 
pressure+ 1/3 (systolic blood pressure- diastolic blood pressure)). Vascular 
conductance is the reciprocal of vascular resistance and is the preferred index of vascular 
tone where large changes in flow occur which is the usual in vivo situation (Lautt, 1989). 
Slope (m) was calculated using the linear regression equation, y = (mlogx) + c, in order to 
' compare the differences in cirazoline-mediated responses between the two strains. The 
measured lumen was corrected using the formula Ac =Am x (Rs IRI) where Ac is the 
corrected area, Am is the measured area, Rs is short radius of lumen, RL is long radius of 
lumen (Smeda et al., 1988). 
All data are presented as mean± SEM. Student's unpaired t-test was used for 
comparisons between hemodynamic values and analysis of variance (ANOVA) with 
repeated measures was used for comparison between hemodynamic, perfusion pressure, 
and membrane potential values. Duncan's multiple range test was used to compare 
between multiple means. In all cases, a probability of error less than 0.05 was selected as 
the criterion for statistical significance. 
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3. RESULTS 
Both the systolic and diastolic blood pressures as well as heart rate of Dahl salt-sensitive 
rats were significantly (P < 0.05) higher than those of Dahl salt-resistant rats 7 weeks 
after they were placed on a 4% salt diet (Table 4 ). While basal mesenteric blood flow 
was not significantly different in Dahl SRN rats in comparison to SSH rats, basal 
mesenteric vascular conquctance was significantly lower in the Dahl SSH when 
compared to SRN rats (Table 4). It was observed that the Dahl SSH rats had a slightly, 
but significantly, higher body weight than Dahl SRN rats 7 weeks after they were placed 
on the salt diet (Table 4 ). In addition, the ratio of right ventricle to the left ventride plus 
septum was significantly smaller in Dahl SSH rats when compared to SRN rats (Table 4) 
indicating the presence of left ventricular hypertrophy in hypertensive animals. 
Moreover, the weight of the kidneys corrected for body weight was found to be greater in 
Dahl SSH than SRN rats on salt diet (Table 4). There were no significant differences 
between the plasma N02-/N03-, plasma volume, and total blood volume between Dahl 
SRN and SSH rats (Table 4). 
3.1. Blood flow measurements 
3.1.1. Effects ofcirazoline in mesenteric bed 
There were no significant differences in the baseline values of mean arterial blood 
pressure, heart rate, superior mesenteric blood flow and mesenteric vascular conductance 
Table 4. Systolic and diastolic blood pressure (mmHg), heart rate (beats min- 1), 
mesenteric blood flow (ml min-1 100g-1), mesenteric vascular conductance (ml min-1 
mmHg-1 lOOg- 1) , body weight (g), ratio of right to left ventricle+ septum (RV/LV+S), 
right kidney (g 1 00 g - I), left kidney (g 100 g -I), plasma nitrate/nitrite (J.J.M), plasma 
volume (ml kg- 1) and total blood volume (ml kg- 1) of Dahl salt-resistant normotensive 
(SRN) and salt-sensitive hypertensive (SSH) rats after 7 weeks on a 4% salt diet. 
Groups SRN SSH 
Blood Pressure 118/80 ± 111 175/126± 1*11* 
Heart Rate 363 ± 3.0 388 ± 6.0* 
Mesenteric Blood Flow1 2.87 ± 0.12 2.67 ± 0.12 
Vascular Conductance 1 0.023 ± 0.001 0.016 ± 0.001* 
Body Weight 230 ± 1.5 255 ± 2.4* 
RV/(LV + S) 0.23 ± 0.003 0.17 ± 0.003* 
Right Kidney 100 g- 1 0.44 ± 0.006 0.53 ± 0.010 • 
Left Kidney 1 00 g - I 0.43 ± 0.005 0.53 ± 0.011* 
Nitrite/Nitrate2 0.8 ± 0.5 1.5 ± 0.5 
Plasma Volume3 49.9± 1.4 48.1±0.7 
Total Blood Volume3 70.7 ± 1.7 73.7 ± 1.0 
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rach value represents the mean ± SEM of 7 6 experiments (I except n = 24; 2except n = 1 0; 
except n = 22) 
*significantly different from Dahl SRN rats; P < 0.05 
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within the groups of Dahl SRN and Dahl SSH rats (Table 5 & 6). Intravenous infusion of 
cirazoline (0.4, 0.8, 1.6, and 3.2 !J.g kg- 1 min-1) produced a dose-dependent increase in 
mean arterial blood pressure, and decrease in heart rate; mesenteric blood flow, and 
mesenteric vascular conductance in all groups. The cirazoline dose-response curve for 
changes in blood pressure was significantly different between Dahl SRN and SSH rats 
(Fig. 3A). The slope values for blood pressure vs. log[cirazoline] were not significantly 
different between the two ·strains (slope = 47.8 ± 2.6 versus 51.8 ± 4.3 respectively; mean 
± SEM). There were no differencess in cirazoline-mediated decrease in mesenteric blood 
flow between the SRN and SSH rats (Fig. 3B). In contrast, cirazoline produced a 
I 
significant! y greater decrease in mesenteric vascular conductance in SRN (slope = 1.13 ± 
0.07 x 103 ; mean± SEM) when compared to SSH rats (slope= 8.44 ± 0.80 x 103; mean± 
SEM) (Fig. 3C). The s!ope values for increase in blood pressure versus decrease in heart 
rate from baseline at various doses of cirazoline were not different between Dahl SRN 
and SSH rats (0.80 ± 0.02 versus 0.88 ± 0.02 beats min-1 mmHg-1; mean± SEM). 
In addition, administration of saline and vehicle did not significantly affect cirazoline-
induced changes in mean arterial blood pressure, heart rate, mesenteric blood flow or 
mesenteric vascular conductance when compared to the effects of cirazoline prior to 
administration of saline and vehicle in Dahl SRN and SSH rats (Fig. 4, 5 & Table 6). 
Table 5. Baseline values of mean arterial blood pressure (MAP; mmHg), superior 
mesenteric arterial blood flow (SMAF; ml min- 1 lOOg- 1) , and superior mesenteric arterial 
conductance (SMAC; ml min- 1 mmHg- 1 lOOg-1) values before and after injection of 
saline+ vehicle, L-NAME (0.3 mg kg- 1) +vehicle, saline+ niflumic acid (10 mg kg- 1) , 
or L-NAME (0.3 mg kg- 1) + niflumic acid (10 mg kg-1) in Dahl anesthetized Dahl salt-
resistant normotensive (S~) and salt-sensitive hypertensive (SSH) rats. 
Table 5 
Groups MAP 
SRN SSH 
Saline + Vehicle Pre 129±4 177±11 a 
Post 122±4 164±12a 
· L-NAME +Vehicle Pre 124±4 168±12a 
Post 136±5b 177±16a 
Saline+ NFA Pre 120±4 166±7a 
Post 122±4 164±8a 
L-NAME+NFA Pre 129±4 167±11a 
Post 141±4b 175±10a 
Each value represents the mean of six experiments ± SEM 
aSignificantly different from the salt-resistant rats; P < 0.05 
bSignificantly different from the predrug value; P < 0.05 
75 
SMAF SMAC 
SRN SSH SRN SSH 
2.86±0.25 2.60±0-:21 0.022±0.002 0.015±0.002a 
2.88±0.32 2.37±0.24 0.024±0.003 0.0 15±0.002a 
3.00±0.19 2.58±0.24 0.024±0.002 0.016±0.002a 
2.48±0.28b 2.20±0.29 0.019±0.003b 0.013±0.002a 
2.69±0.19 2.65±0.26 0.026±0.004 0.016±0.002a 
2.89±0.39 2.26±0.23ab 0.024±0.003 0.014±0.001 a 
2.59±0.13 2.88±0.31 0.020±0.001 0.018±0.002a 
2.18±0.23b 1.99±0.16ab 0.016±0.002b 0.0 12±0.00 1 ab 
Table 6. Heart rate (beats miR-1) values in different groups of animals before (Pre) and 
after (Post) treatment with saline (0.9% NaCl) +vehicle (0.4 M NaHC03 in 5% glucose), 
L-NAME (0.3 mg kg- 1) +vehicle, saline+ niflumic acid (10 mg kg- 1), and L-NAME + 
niflumic acid during infusion with various doses of cirazoline (!lg kg-1 min- 1) in 
anesthetized Dahl salt-resistant normotensive (SRN) salt-sensitive hypertensive (SSH) 
rats. 
Table 6 
Groups Saline + Vehicle L-NAME +Vehicle 
Pre Post Pre 
Control SRN 348±3 348±11 342±11 
SSH 390±12 382±13 370±16 
Cirazoline 0.4 SRN 313±1 oa 323±11 a 315±12 
SSH 387±10 377±11 360±22 
0.8 SRN 290±13a 297±9ab 288±13ab 
SSH 368±16 367±14 343±23a 
1.6 SRN 290±9a 285±8ab 290±11 ab 
SSH 350±19ab 347±17a 327±21 ab 
3.2 SRN 288±10a 277±9ab 290±10ab 
SSH 333±18abc 323±18abc 31 0±17abc 
. Each value represents mean of six experiments ± SEM 
aSignificantly different from Control value; P < 0.05 
bSignificantly different from 0.4 J.!g kg- 1 min- 1; P < 0.05 
cSignificantly different from 0.8 J.!g kg-1 min-1; P < 0.05 
Post 
322±13 
337±9 
. 302±12 
330±15 
297±12a 
313±21 
290±10a 
302±19a 
285±10a 
287±17ab 
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Saline+ NFA L-NAME+NFA 
Pre Post Pre Post 
350±10 357±9 364±7 348±6 
388±14 . 388±24 383±10 348±12 
330±11 a 337±5 340±7a 322±3a 
363±21 372±22 372±11 333±8 
303±7a 317±7ab 300±7ab 314±2a 
330±31 348±16 342±16a 322±6 
285±7ab 303±rb 302±3ab 304±2a 
327±20 325±11 a 323±17ab 303±12a 
280±9ab 293±6abc 304±4ab 286±9ab 
317±14a 312±9a 300±17abc 303±13a 
Figure 3. Cirazoline dose-response curve for (A) mean arterial blood pressure (MAP), 
(B) superior mesenteric arterial blood flow (SMAF), and (C) superior mesenteric arterial 
conductance (SMAC) obtained from Dahl salt-resistant normotensive (SRN) (closed 
circles) and Dahl salt-sensitive hypertensive (SSH) (opened circles) rats. Each value 
represents mean± SEM of24 experiments. ·significantly different from corresponding 
value in Dahl SRN rats; P < 0.05 . 
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Figure 4. Cirazoline dose-response relationship in the absence (open bars) and presence 
of saline (0.9% NaCl) and vehicle (0.4 M NaHC03 in 5% glucose; hatched bars) on (A) 
mean arterial blood pressure (MAP), (B) superior mesenteric arterial blood flow (SMAF), 
and (C) superior mesenteric arterial conductance (SMAC) obtained from Dahl salt-
resistant normotensive (SRN) rats. Each value represents mean± SEM of six 
experiments, and is a percentage of control prior to infusion of cirazoline. 
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0.8 1.6 3.2 
Cirazoline (mg kg-1 min-1) 
Figure 5. Cirazoline dose-response relationship in the absence (open bars) and presence 
of saline (0.9% NaCl) and vehicle (0.4 M NaHC03 in 5% glucose; hatched bars) on (A) 
mean arterial blood pressure (MAP), (B) superior mesenteric arterial blood flow (SMAF), 
and (C) superior mesenteric arterial conductance (SMAC) obtained from Dahl salt-
sensitive hypertensive (SSH) rats. Each value represents mean± SEM of six 
experiments, and is a percentage of control prior to infusion of cirazoline . 
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3.1.2. Effects of L-NAME on vascular effects of cirazoline in mesenteric bed 
Bolus intravenous injection ofL-NAME (0.3 mg kg- 1) significantly increased the 
baseline value of mean arterial blood pressure and decreased mesenteric blood flow and 
mesenteric vascular conductance in Dahl SRN rats but not in Dahl SSH rats (Table 5). 
Administration of L-NAME did not affect cirazoline-mediated increases in blood pressure 
or decreases in heart rate when compared to control in either strains (Fig. 6A, 7 A & Table 
6). L-NAME was found to blunt cirazoline-mediated reduction in mesenteric blood flow 
and vascular conductance in SRN rats (Fig. 6BC). In SSH rats, L-NAME blunted 
I 
cirazoline-mediated reduction in mesenteric blood flow but not vascular conductance 
(Fig. 7BC). 
3.1. 3. Effects of niflumic acid on vascular effects of cirazoline in mesenteric bed 
Bolus intravenous injection ofniflumic acid (10 mg kg- 1) did not affect the baseline 
values of mean arterial blood pressure, mesenteric blood flow, mesenteric vascular 
conductance and heart rate in Dahl SRN rats, while in the SSH rats, mesenteric blood 
flow was reduced but not mesenteric vascular conductance or blood pressure or heart rate 
(Table 5, 6) . 
Administration of niflumic acid did not affect cirazoline-mediated increases in mean 
arterial blood pressure or decreases in heart rate when compared to control in either 
strains ofrat (Fig. SA, 9A & Table 6). However, cirazoline-mediated reduction in 
Figure 6. Cirazoline dose-response relationship in the absence (open bars) and presence 
ofL-NAME (0.3 mg kg- 1; hatched bars) and vehicle (0.4 M NaHC03 in 5% glucose) on 
(A) mean arterial blood pressure (MAP), (B) superior mesenteric arterial blood flow 
(SMAF), and (C) superior mesenteric arterial conductance (SMAC) obtained from Dahl 
salt-resistant normotensive (SRN) rats. Each value represents mean± SEM of six 
experiments, and is a percentage of control prior to infusion of cirazoline. *significantly 
' 
different from respective pre-drug value; P < 0.05. 
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Figure 7. Cirazoline dose-response relationship in the absence (open bars) and presence 
of L-NAME (0.3 mg kg- 1; hatched bars) and vehicle (0.4 M NaHC03 in 5% glucose) on 
(A) mean arterial blood pressure (MAP), (B) superior mesenteric arterial blood flow 
I 
(SMAF), and (C) superior mesenteric arterial conductance (SMAC) obtained from Dahl 
salt-sensitive hypertensive (SSH) rats. Each value represents mean± SEM of six 
experiments, and is a percentage of control prior to infusion of cirazoline. *significantly 
. 
different from respective pre-drug value; P < 0.05 . 
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3.2 
Figure 8. Cirazoline dose-response relationship in the absence (open bars) and presence 
of saline (0.9% NaCl) and niflurnic acid (10 mg kg- 1; hatched bars) on (A) mean arterial 
blood pressure (MAP), (B) superior mesenteric arterial blood flow (SMAF), and (C) 
superior mesenteric arterial conductance (SMAC) obtained from Dahl salt-resistant 
normotensive (SRN) rats. Each value represents mean± SEM of six experiments, and is 
a percentage of control prior to infusion of cirazoline. *significantly different from 
. 
respective pre-drug value; P < 0.05. 
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Figure 9. Cirazoline dose-response relationship in the absence (open bars) and presence 
of saline (0.9% NaCl) and niflumic acid (10 mg kg-1; hatched bars) on (A) mean arterial 
blood pressure (MAP), (B) superior mesenteric arterial blood flow (SMAF), and (C) 
superior mesenteric arterial conductance (SMAC) obtained from Dahl salt-sensitive 
hypertensive (SSH) rats. Each value represents mean ± SEM of six experiments, and is a 
percentage of control prior to infusion of cirazoline. *significantly different from 
respective pre-drug value; P < 0.05. 
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3.2 
93 
mesenteric blood flow and mesenteric vascular conductance at all the doses of a1-
adrenoceptor agonist in Dahl SRN rats was significantly attenuated following niflumic 
acid treatment (Fig. 8BC). In the SSH rats, treatment with niflumic acid was only able to 
attenuate cirazoline-mediated reduction in mesenteric blood flow and mesenteric vascular 
conductance at the lower dose of a 1-adrenoceptor agonist (Fig. 9BC). 
3.1. 4. Effect of concomitant administration of L-NAME and niflumic acid on vascular 
effects of cirazoline in mesenteric bed 
Bolus intravenous injection ofL-NAME (0.3 mg kg- 1) and niflumic acid (10 mg kg- 1) 
significantly increased the baseline value of blood pressure and attenuated mesenteric 
blood flow and vascular conductance in SRN rats. In the SSH rats, the combination of L-
NAME and niflumic acid reduced the baseline values of mesenteric blood flow and 
vascular conductance but not blood pressure or heart rate (Table 5 & 6). 
Administration of L-NAME and niflumic acid combined significantly attenuated 
cirazoline-mediated increase in blood pressure in the SRN but not in SSH rats (Fig. 1 OA, 
11 A). In contrast to the actions of niflumic acid alone, the concomitant administration of 
L-NAME and niflumic acid significantly attenuated a 1-adrenoceptor mediated reduction 
in mesenteric blood flow and vascular conductance in a similar manner in both strains 
(Fig. 1 OBC, 11 BC). The inhibitory effect was significant at all four doses of cirazoline in 
Dahl SRN as well as SSH rats. 
Figure 10. Cirazoline dose-response relationship in the absence (open bars) and presence 
ofL-NAME (0.3 mg kg- 1) and niflumic acid (10 mg kg-1; hatched bars) on (A) mean 
arterial blood pressure (MAP), (B) superior mesenteric arterial blood flow (SMAF), and 
(C) superior mesenteric arterial conductance (SMAC) obtained from Dahl salt-resistant 
normotensive (SRN) rats. Each value represents mean± SEM of six experiments, and is 
a percentage of control priqr to infusion of cirazoline. "significantly different from 
respective pre-drug value; P < 0.05. 
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3.2 
Figure 11. Cirazoline dose-response relationship in the absence (open bars) and presence 
ofL-NAME (0.3 mg kg- 1) and niflumic acid (10 mg kg-1; hatched bars) on (A) mean 
arterial blood pressure (MAP), (B) superior mesenteric arterial blood flow (SMAF), and 
I (C) superior mesenteric arterial conductance (SMAC) obtained from Dahl salt-sensitive 
hypertensive (SSH) rats. Each value represents mean± SEM of six experiments, and is a 
percentage of control prior to infusion of cirazoline. *significantly different from 
respective pre-drug value; P < 0.05. 
97 
0 
8 
0 
-....-
I 
-10 rn 
0 
0 
....- -20 
I 
c 
.E 
-30 
E 
~ 
u.. -40 
<{ 
~ 
U) 
-50 
c 
Q) 
-60 rn 
c 
ro 
J:: 
-70 () 
~ 0 
-80 
c 
....- 0 I 
rn 
0 
0 
-10 
....-
I 
-20 rn 
:r: 
E 
-30 E 
....-
I 
-40 c 
E 
E -50 
~ 
u 
-60 <{ 
~ 
U) 
-70 
c 
Q) 
-80 rn 
c 0.4 ro 0.8 1.6 3.2 
J:: 
-90 () 
~ 0 
Figure 11 
l 
3.2. Studies in isolated perfused mesenteric bed preparation 
3. 2.1. Effect of cirazoline in isolated mesenteric bed perfused with normal Krebs and 
cr-.free buffer 
98 
The basal perfusion pressures in isolated mesenteric arteries of Dahl SRN and SSH rats, 
perfused with normal Krebs, were 22.6 ± 1.2 and 21.0 ± 1.2 mmHg (mean ± SEM; n = 
36), respectively. There was no significant difference between basal perfusion pressures 
of Dahl SRN versus SSH rats. Bolus injections of cirazoline (0.1-30 nmoles) evoked 
dose-dependent constrictor responses in the isolated mesenteric arteries from Dahl SRN 
and SSH rats (Fig 12-17). Cirazoline-evoked increases in perfusion pressure were found 
not to be significantly different between the Dahl SRN and SSH rats (Fig 12-17). 
Addition of vehicle in normal Krebs buffer did not significantly affect cirazoline-evoked 
vasoconstriction when compared to the effects of cirazoline prior to administration of 
vehicle in Dahl SRN and SSH rats (Fig 12AB). 
A switch of perfusion medium from normal Krebs to C1--free buffer produced a transient 
increase in perfusion pressure which returned to basal levels within 10 min. This 
transient increase in perfusion pressure in C1--free buffer was significantly smaller in 
Dahl SRN when compared to SSH rats (26.4 ± 3 and 44.1 ± 7 mmHg, respectively; mean 
± SEM; n = 12). In C1--free buffer when compared to normal Krebs, cirazoline-induced 
vasoconstriction in blood vessels from Dahl SRN rats was significantly attenuated at the 
Figure 12. Cirazoline dose-response relationship in rat isolated mesenteric arterial beds 
obtained from Dahl salt-resistant normotensive (SRN) (A) and salt-sensitive hypertensive 
(SSH) (B) rats, perfused with normal Krebs in the absence (open columns) and the 
I 
presence of vehicle (0.4 M NaHC03; hatched columns). Each value represents the mean 
of six experiments ± SEM. 
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Figure 13. Cirazoline dose-response relationship in rat isolated mesenteric arterial beds 
obtained from Dahl salt-resistant normotensive (SRN) (A) and salt-sensitive hypertensive 
(SSH) (B) rats, perfused with normal Krebs (open columns) and with C1--free buffer 
(hatched columns). Each value represents the mean of six experiments± SEM. 
asignificantly different from value in normal Krebs; P < 0.05. 
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Figure 14. Cirazoline dose-response relationship in rat isolated mesenteric arterial beds 
obtained from Dahl salt-resistant normotensive (SRN) (A) and salt-sensitive hypertensive 
(SSH) (B) rats, perfused with normal Krebs in the absence (open columns) and the 
( 
presence ofL-NAME (10 !lM; hatched columns). Each value represents the mean of six 
experiments ± SEM. asignificantly different from value in normal Krebs. bsignificantly 
different from corresponding value in Dahl SRN rats; P < 0.05 . 
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Figure 15. Cirazoline dose-response relationship in rat isolated mesenteric arterial beds 
obtained from Dahl salt-resistant normotensive (SRN) (A) and salt-sensitive hypertensive 
(SSH) (B) rats, perfused with normal Krebs buffer (open columns) and Cl--free buffer in 
the presence ofL-NAME (10 ~-tM ; hatched columns). Each value represents the mean of 
six experiments± SEM. asignificantly different from value in normal Krebs; P < 0.05. 
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Figure 16. Cirazoline dose-response relationship in rat isolated mesenteric arterial beds 
obtained from Dahl salt-resistant normotensive (SRN) (A) and salt-sensitive hypertensive 
(SSH) (B) rats, perfused with normal Krebs in the absence (open columns) and the 
presence ofniflumic acid (10 j..I.M; hatched columns). Each value represents the mean of 
six experiments ± SEM. 3significantly different from value in normal Krebs. 
bsignificantly different from corresponding value in Dahl SRN rats; P < 0.05 . 
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Figure 17. Cirazoline dose-response relationship in rat isolated mesenteric arterial beds 
obtained from Dahl salt-resistant normotensive (SRN) (A) and salt-sensitive hypertensive 
(SSH) (B) rats, perfused with normal Krebs buffer (open columns) and cr-free buffer in 
f 
the presence ofniflumic acid (10 1-1M; hatched columns). Each value represents the mean 
of six experiments± SEM. asignificantly different from value in normal Krebs; P < 0.05. 
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higher administered three doses (3-30 nmoles), but in contrast, there were no significant 
changes in Dahl SSH rats (Fig 13AB). 
3.2.2. Effect of L-NAME on cirazoline-induced vasoconstriction in isolated mesenteric 
bed perfused with normal Krebs and Cr -free buffer 
The addition ofL-NAME (10 J.lM) to the perfusate either in normal Krebs or Cl--free 
buffer did not result in a•change in the basal perfusion pressure in blood vessels from 
Dahl SRN and SSH rats. The presence ofL-NAME in normal Krebs buffer enhanced the 
vasoconstrictor actions of cirazoline in Dahl SRN rats (0.3-30 nmoles), while it had no 
f 
significant effect in Dahl SSH rats (Fig 14AB). Moreover, the cirazoline dose-response 
relationship in the presence ofL-NAME in normal Krebs was significantly different 
between the two strains (Fig 14AB). 
In Cl--free buffer, the addition ofL-NAME caused a significant potentiating effects at the 
lower doses of cirazoline (0.3 and 1.0 nmoles) while inhibiting cirazoline-mediated 
effects at the higher dose (30 nmoles) in Dahl SRN rats (Fig 15A). In contrast to the 
latter, the presence ofL-NAME in C1--free buffer did not have any significant effect on 
cirazoline-mediated responses in blood vessels from Dahl SSH rats (Fig 15B). 
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3. 2. 3. Effect of niflumic acid on cirazoline-induced vasoconstriction in isolated 
mesenteric bed perfused with normal Krebs and Cr-jree buffer 
The addition ofniflumic acid (10 llM) to the perfusate either in normal Krebs or C1--free 
buffer did not result in a change in the basal perfusion pressure in blood vessels from 
Dahl SRN and SSH rats. The presence of niflumic acid in the normal Krebs significantly 
attenuated the vasoconstrictor actions of cirazoline in Dahl SRN (0.3-30 nmoles) and 
SSH rats (1-10 nmoles)' (Fig 16AB). The inhibitory action ofniflumic acid was 
significantly 
more pronounced in blood vessels from Dahl SRN when compared to SSH rats (Fig 
16AB). 
The presence of niflumic acid in C1--free buffer did not produce any additional inhibition 
. 
of cirazoline-mediated vasoconstriction in blood vessels of either Dahl SRN or SSH rats 
when compared to the action of niflumic acid in normal Krebs (Fig 17 AB). 
3.3. Electrophysiological investigation in superior mesenteric artery 
The resting membrane potential of smooth muscle cells in normal Krebs buffer from Dahl 
SRN rats and SSH rats was -67.8 ± 0.4 mV (mean± SEM; n = 16) and -67.3 ± 0.5 mV 
(mean ± SEM; n = 16), respectively. There was no significant difference between the 
resting membrane potential of smooth muscle cells between the two strains (Table 7). 
Perfusion with cirazoline (3 llM) in normal Krebs did not produce any depolarization of 
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Table 7. Resting membrane potential (mV) recorded from superior mesenteric artery 
from Dahl salt-resistant normotensive (SRN) and salt-sensitive hypertensive (SSH) rats 
on a 4% salt diet for 7 weeks 
Groups 
SRN 
SSH 
SRN 
SSH 
SRN 
SSH 
NK 
-67.7 ± 0.6 (30)(5) 
-67.4 ± 1.2 (27)(5) 
NK 
-68.3 ± 0.8 (32)(6) 
-67.7 ± 0.8 (31)(5) 
NK 
-67.4 ± 1.2 (26)(5) 
-67.0 ± 1.0 (30)(6) 
Cirazoline Post-Cirazoline 
-67.0 ± 0.8 (35)(5) -68.2 ± 0.8 (20)(5) 
-67.1 ± 1.2 (38)(5) -68.9 ± 0.9 (27)(5) 
C1--free C1--free + Cirazoline 
-60.8 ± 1.2a (35)(6) -62.1 ± l.Oa qs)(6) 
-57.7 ± 0.8ab (38)(5) -56.0 ± 1.2ab (37)(5) 
NK+L-NAME NK+L-NAME+ 
Cirazoline 
-61.8 ± 1.9a (36)(5) -61.6 ± 1.2a (34)(5) 
-67.3 ± 0.4b (34)(6) -68.7 ± 0.9b (31)(6) 
Each value represents mean of 5-6 experiments ± SEM. Number in parenthesis 
represents number of cells and tissues, respectively. 
aSignificantly different from normal Krebs (NK); P < 0.05 
bSignificantly different from SRN rats; P < 0.05 
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vascular smooth muscle cells of either Dahl SRN or SSH rats (Table 7). However, 
exposure of blood vessels to cr-free buffer caused a significant depolarization in smooth 
muscle cells from Dahl SRN and SSH rats 10 min after switching the perfusion medium 
from normal Krebs to Cl--free buffer (Table 7). The latter depolarization was 
significantly larger in Dahl SSH rats when compared to SRN rats. The addition of 
cirazoline in Cl--free buffer did not produce any additional depolarization of smooth 
muscle cells in either SRN or SSH rats. While perfusion with L-NAME (1 0 !J.M) resulted 
in a significant depolarization of vascular smooth muscle cells in Dahl SRN, it did not do 
so in SSH rats (Table 7). Addition of cirazoline in combination with L-NAME did not 
I 
cause any additional depolarization of smooth muscle cells from SRN or any change in 
the resting membrane potential of vascular smooth muscle cells in SSH rats (Table 7). 
3.4. Morphometric assessment in primary mesenteric blood vessels 
Morphological examination of sections of the primary mesenteric arteries revealed 
significantly larger perimeter, lumen area, smooth muscle wall thickness, and lumen 
diameter in blood vessels from Dahl SSH rats when compared to SRN rats (Table 8). 
Interesting! y, while smooth muscle thickness and lumen diameter were found to be 1. 8 
and 1.4 fold greater in SSH compared to SRN rats, the ratio of smooth muscle thickness 
to lumen diameter (0.35 ± 0.03 versus 0.41 ± 0.03) was found not to be significantly 
different between the two strains (Table 8). In contrast, the primary mesenteric veins 
from Dahl SRN and SSH rats did not reveal any difference in perimeter, lumen area, 
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Table 8. Morphometric measurements from primary mesenteric arteries from Dahl salt-resistant normotensive (SRN) and salt-
sensitive hypertensive (SSH) rats on a 4% salt diet for 7 weeks. 
Group 
SRN 
SSH 
Perimeter (11m) 
319±18 
487 ± 24* 
6927 ± 909 
13516 ± 1407* 
Each value represents mean of 22 experiments ± SEM 
Smooth muscle 
wall thickness 
(IJ.m) 
28.0 ± 1.0 
50.4 ± 2.8 • 
*Significantly different from corresponding value in SRN rats; P < 0.05 
Lumen diameter 
(11m) 
90 ± 6 
124 ± 7* 
Smooth muscle 
thickness/lumen 
diameter 
0.35 ± 0.03 
0.41 ± 0.03 
smooth muscle wall thickness, lumen diameter, or ratio of smooth muscle thickness to 
lumen diameter (0.06 ± 0.01 versus 0.07 ± 0.01) (Table 9). There were significant 
differences noted between the morphology of primary mesenteric arteries compared to 
veins in Dahl SRN and SSH rats (Table 8 & 9). 
116 
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Table 9. Morphometric measurements from primary mesenteric veins from Dahl salt-resistant normotensive (SRN) and salt-
sensitive hypertensive (SSH) rats on a 4% salt diet for 7 weeks. 
Group Perimeter (Jlm) Lumen area (J1m2) Smooth muscle Lumen diameter Smooth muscle 
wall thickness (Jlm) thickness/lumen 
(!-1m) diameter 
SRN 619±68* 21871 ± 3442* 7.84 ± 0.8 • .161 ± 14* 0.06 ± 0.01 • 
SSH 648 ± 35* 20842 ± 3690* 11.07 ± 0.8 • 157 ± 14* 0.07 ± 0.01 * 
Each value represents mean of 10 experiments ± SEM 
*Significantly different from corresponding value in mesenteric arteries; P < 0.05 
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4. DISCUSSION 
There is evidence to suggest that a high-salt diet is a factor responsible in the 
development of hypertension in susceptible human and experimental models (Tobain, 
1991; Simchon et al., 1991 ). The Dahl salt-sensitive rats develop high blood pressure 
when placed on a high-salt diet, whereas the salt-resistant rats do not (for review see 
Rapp, 1982). The evidt(nce in the current literature seems to suggest that the development 
of high blood pressure in the Dahl salt-sensitive rat is graded and primarily depends on 
the amount (Pfeffer et al., 1984) and the duration of the salt diet (Simchon eta!., 1991 ). 
Ganguli et a!. ( 1979) have reported when Dahl salt-resistant rats are placed on an18% salt 
diet for 3 days, cardiac output increased and peripheral resistance decreased by 18% and 
14% respectively, while the average blood pressure remained the same (110 versus 112 
mmHg). In contrast, with a similar salt diet duration in Dahl salt-sensitive rats, the 
cardiac output and peripheral resistance increased by 10% each, and the arterial pressure 
became elevated by approximately 20% when compared to rats on a low-salt diet (133 
versus 111 mmHg) (Ganguli et al., 1979). Based on the assumption that blood pressure is 
the product of cardiac output and total peripheral vascular resistance it can be suggested 
that the early elevation in blood pressure appears to be due to increases in both cardiac 
output and total peripheral resistance. However, the latter theory is not supported by 
evidence presented by Simchon eta!. (1991 ). They have reported that at 4 weeks the 
hemodynamic basis for hypertension in salt-sensitive rats on an 8% salt was primarily due 
to increased cardiac output, without any change in the total peripheral resistance. 
However, at 8 weeks the situation was reversed and cardiac output was reduced while 
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total peripheral resistance increased (Simchon et a!. , 1991 ). In light ofthese findings, it 
seems that in the Dahl salt-sensitive rat, cardiac output is elevated only in the early stages 
of high salt consumption, and that the continued development of high arterial pressure in 
this model subsequently is due to a progressive rise in total peripheral resistance 
(Boegehold eta!. , 1991 ; Simchon eta!. , 1991). Perhaps not surprisingly, similar data has 
also been presented in humans. It has been demonstrated that normotensive subjects on 
high-salt diet produced forearm vasodilation and failed to increase arterial pressure 
significantly, whereas the hypertensive subjects augmented forearm vasoconstrictor 
responses and had elevated blood pressure, perhaps suggesting the hemodynamic basis of 
elevated blood pressure in the subpopulation was due to increased peripheral resistance 
(Market a!. , 1975). 
Associated with these hemodynamic changes within the circulatory system during the 
development of salt-induced hypertension there appears to be significant alteration in the 
behavior of blood vessels in these animals (LUscher et al. , 1987; Tabrizchi and Duggan, 
2000). These alterations in behavior manifest themselves in term of change in 
morphological (Lee and Triggle, 1986; Intengan and Schiffrin, 1998), mechanical 
(Nishida et al. , 1998; Tabrizchi and Duggan, 2000), and electrical (Fujii et al., 1997) 
activity of smooth muscle cells. In addition, alteration in the interrelationship between 
smooth muscle and endothelial cells also seems to occur (Tabrizchi and Duggan, 2000). 
Collectively, these changes appear to contribute to difference in the behavior of blood 
vessels in salt-induced hypertension when compared to salt-resistant normotensive rats 
(LUscher et a!. , 1987; Nishida et al., 1998). Against this background, the current 
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investigation was undertaken to assess the hemodynamic, electrical, mechanical, and 
morphological differences in mesenteric blood vessels from Dahl SRN and SSH rats 
placed on a 4% salt diet for 7 weeks. 
4.1. Hemodynamic measurements 
4.1.1. Blood pressure and heart rate 
In the present study, it was found that the female Dahl salt-sensitive rats had significantly 
higher blood pressure and were hypertensive whereas the salt-resistant rats remained 
I 
normotensive after 7 weeks on a 4% salt diet. The evidence in the literature also suggest 
that the Dahl salt-sensitive rats had a higher blood pressure when compared to salt-
resistant rats on a 4% salt diet ( 15211 09 ± 919 versus 120/83 ± 4/5 mmHg) (Laher and 
Triggle, 1984) (180/130 ± 111 versus 101/76 ± 111 mmHg) (Tabrizchi and Duggan, 2000). 
In this study, a 4% salt diet was used because 8% salt treatment has been suggested to 
result in development of severe hypertension where mortality rate is high over a 7 week 
time frame. Tobain (1991) have reported a 53% mortality rate in Dahl hypertensive rats 
placed on an 8% salt diet for 8 weeks. This experimental design was designed to produce 
a moderate elevation of blood pressure with low mortality in animals placed on a high-
salt diet. The mortality rate associated with the present investigation was 10%. 
Moreover, the average amount of salt commonly present in an adult human American diet 
is about 2% (Tobain, 1991) and hence using 4% salt seems more closely related to human 
121 
salt intake. Laher (1983) has reported that Dahl salt-sensitive rats develop a blood 
pressure of 151/109 ± 617 mmHg and 207/135 ± 17/21 mmHg (using indirect tail-cuff 
method) on 4% and 8% salt diet, respectively. Similarly, Pfeffer et al. (1984), using the 
same indirect blood pressure measurement, have reported that Dahl salt-sensitive rats 
developed a mean blood pressure of 148 ± 4 mrnHg on a 4% salt diet and 193 ± 6 mmHg 
on an 8% salt diet. The blood pressure of the halothane anesthetized Dahl salt-sensitive 
rats used in the present 'study were 175/126 ± 1/1 mmHg, measured using intra-arterial 
catheter, after 7 weeks on a 4% salt diet. Based on the published data in the literature it 
would not be unreasonable to suggest that the elevated blood pressure in these rats at this 
stage of hypertension was due to an elevated peripheral resistance consistent with reduced 
conductance measured here (Ganguli et al., 1979; Simchon et al., 1991). 
There was no particular reason for using female Dahl rats except that these have been 
used previously in our laboratory. In fact, it has been suggested that there is no sex 
difference in the response of blood pressure to high salt intake in Dahl rats (Dobesova et 
al. , 1995), although the mortality rate of the female rats was found to be lower compared 
to the male rats on high-salt diet (Bayorh et al., 2001 ). 
In this study, the heart rate from Dahl SSH rats was significantly higher when compared 
to SRN rats. However, others have reported that heart rate was not different between the 
Dahl SRN and SSH rats on low- and high-salt diets, although there were a tendency of 
higher heart rate in SSH rats (He et al., 1997; Bayorh eta/., 1998). The sample size (n = 
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76 versus n = 10 and 20, respectively; P < 0.05) was quite large compared to others, 
which might be why the results reached a statistical significance level. Based on the 
present data it can be suggested that the increase in arterial blood pressure in Dahl SSH 
rats might be associated with an increase in heart rate. 
4.1. 2. Superior mesenteric arterial blood flow 
In the present study, the basal mesenteric blood flow is slightly but not significantly 
higher in the Dahl SRN compared to SSH rats. According to Poiseuille's law, flow is 
directly proportional to the forth power of the radius of the blood vessel (Q oc /;where Q 
represents rate of blood flow through a vessel and r represents radius ofthe blood vessel). 
This might represent a slight difference in radius of the blood vessels and suggests that 
the blood vessels from SSH rats are in a constricted state. Conductance is the reciprocal 
of resistance (R) and hence can be given as flow/pressure gradient (FI!JP) (Lautt, 1989). 
Indeed, change in conductance rather than blood flow in a blood vessel is a more 
appropriate index of function as flow is normalized for any change in pressure in 
calculation of values of conductance (Lautt, 1989). In this study, it was found that the 
basal mesenteric vascular conductance was significantly lower in Dahl SSH rats 
indicating increased peripheral resistance in mesenteric blood vessels which might be, in 
part, due to reduced basal NO release in the latter blood vessels (for review see Marin and 
Rodriguez-Martinez, 1997). In spite of a constricted artery, mesenteric blood flow was 
not significantly different between the two strains owing to the presence of high pressure 
in blood vessel of SSH rats as can be explained by Ohm' s law if we assume that P is the 
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pressure difference and R is the peripheral resistance (i.e., F = PIR). Furthermore, it 
seems that organ blood flow measured using microspheres in conscious rats indicates that 
the flow rates of the brain, heart, lung, liver, spleen, intestine, skeletal muscle, and skin 
are not different between Dahl SRN and SSH rats (He et al. , 1997). In contrast, the rate 
of blood flow to the kidney was significantly reduced in Dahl SSH when compared to 
SRN rats (He et al., 1997). Taken together, it can be inferred that although the blood 
flow to the mesenteric bed is not different between the Dahl SRN and SSH rats, the 
conductance is significantly reduced suggesting that the increase in blood pressure is most 
likely due to increased resistance to flow. The observation that superior mesenteric blood 
I 
flow remained constant in Dahl SSH rats despite increases in perfusion pressure (BP) can 
be attributed to autoregulation. The maintenance of constant flow despite changes in 
arterial pressure is called autoregulation. 
Cardiac output measured in anesthetized rats using electromagnetic flow probes and 
microspheres was 180-250 (Kawaue and Iriuchijima, 1984) and 291-343 (Tabrizchi and 
Pang, 1993) ml min- 1 kg- 1, respectively. Furthermore, superior mesenteric blood flow 
measured using implanted flow probe in conscious spontaneously hypertensive (4.78 ± 
1.54 ml min- 1 100g- 1) and control (4.36 ± 0.66 ml min-1 100g-1) rats were found not to be 
different between the two strains (Iriuchijima, 1983). Based on the values reported for 
cardiac output in rat, the blood flow to superior mesenteric artery seems to contribute to 
about 15% ofthe total cardiac output (Tabrizchi and Pang, 1993; lida, 1995). Taking into 
account the cardiac output values obtained using electromagnetic flow probe (Kawaue 
.. 
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and Iriuchijima, 1984), the superior mesenteric artery seems to receive 12-14% ofthe 
total cardiac output in Dahl rats. Adding together the celiac blood flow, the gut receives a 
total of 20% of the cardiac output (Iida, 1995). Thus, it is not unreasonable to suggest 
that this bed contributes substantially to the overall peripheral resistance and therefore 
blood pressure of these animals. 
4.1.3. Plasma volume and total blood volume 
The body weight of Dahl SSH was significantly higher when compared to SRN rats on a 
salt diet for 7 weeks in the present study. Previous data from our laboratory also suggest 
I 
an increase in body weight of Dahl SSH when compared to SRN rats on a high-salt diet 
(Tabrizchi and Duggan, 2000; Bieger et al. , 2004 ). In contrast, others have reported a 
decrease (De Simone et al. , 1996; Intengan and Schiffrin, 1998) or no difference (Ganguli 
et al. , 1979; Pfeffer et al. , 1984) in body weight in SSH when compared to SRN rats on a 
salt diet. Despite the higher body weight in Dahl SSH rats, there was no expansion of 
plasma volume and total blood volume in SSH rats in this study. Greene et al. (1990) 
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measured blood volume for 3 days using Cr-labeled erythrocytes and have reported an 
increase in blood volume in both Dahl SRN and SSH rats on an 8% salt diet which were 
not different between the two groups. Dobesova et al. (1995) used Evans blue to measure 
blood volume and has also reported that the blood volume was not different between the 
two strains on a salt diet. However, since blood volume of SRN and SSH rat was not 
significantly different it can be assumed that hypertension in Dahl salt-sensitive rat is 
probably not due to an abnormal increase in blood volume (Greene et al. , 1990; Dobesova 
et al., 1995). In contrast, Simcho.n et al. (1991) using 51Cr-labeled erythrocytes to 
125 
measure blood volume have reported that the Dahl SSH rats on an 8% salt diet had a 
significant expansion of blood volume at 4 and 8 weeks when compared to SRN rats. 
The current data seems to support the view that a transient increase in blood volume 
occurs initially during high salt intake after which the blood volume returns to normal 
levels (Greene et al. , 1990). The consensus seems to be that blood volume increases, but 
about the same in Dahl SRN and SSH rats (Greene et al., 1990; Dobesova et al., 1995). 
4.1. 4. Left ventricular hypertrophy 
It is recognized that a prolonged volume expansion and/or increase in afterload (i.e. 
j 
increase peripheral resistance) will ultimately lead to ventricular hypertrophy. There are 
several studies that suggest a link between salt intake and left ventricular growth in both 
experimental (Meggs et al., 1988; De Simone et al. , 1996) and clinical conditions 
(Schmieder et al., 1988). For example, it has been reported that salt ingestion is a 
powerful determinant of left ventricular hypertrophy in patients with essential 
hypertension (Schmieder et al. , 1988; Du Cailar et al., 1989). The explanation offered is 
that saline overload leads to volume overload and increases left ventricular mass. Thus 
dietary salt restriction promotes regression of cardiac hypertrophy (for review see Coca 
and De la Sierra, 1997). In the experimental situation, Pfeffer et al. (1984) have indicated 
that the Dahl salt-sensitive rats develop graded ventricular hypertrophy in response to salt 
intake. They have demonstrated that the increase in left ventricular weight in salt-
sensitive rats was related to the level of arterial pressure. Essentially, it was demonstrated 
that the left ventricular weights of the salt-sensitive rats were 14%, 32%, and 54% greater 
than those of the salt-resistant rats on their respective low (0.4%), moderate (4%), and 
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high (8%) salt diets (Pfeffer eta!., 1984 ). In addition, De Simone eta!. ( 1996) had also 
indicated that left ventricular hypertrophy is more marked in Dahl salt-sensitive than in 
salt-resistant rats. 
Two forms of left ventricular hypertrophy may be distinguished: concentric and eccentric 
hypertrophy (for review see Coca and De la Sierra, 1997). When the primary stimulus to 
hypertrophy is left ventr~cular pressure overload, there is a resultant rise in intracavitary 
pressure, which leads to a progressive thickening of the ventricular wall and enhanced 
wall thickness/chamber radius ratio leading to concentric hypertrophy (Grossman et al., 
i 
1975). However, when the primary stimulus is left ventricular volume overload, there is 
left ventricular chamber enlargement, which leads to an increase in the internal 
ventricular diameter and a normal wall thickness/chamber radius ratio leading to eccentric 
hypertrophy (Grossman et al., 1975). Now, if the peripheral resistance is elevated, a 
greater load is placed on the heart and this increase in afterload will eventually result in 
increased left ventricular wall mass (Grossman et al., 1975). In this study, an increase in 
blood pressure but not in blood volume was observed in the Dahl SSH when compared to 
SRN rats suggesting that the left ventricular hypertrophy observed is most likely 
concentric and is due to increased peripheral resistance (i.e. impedance to flow). 
Although it is also possible that volume overload in response to salt loading occurred 
prior to 7 weeks on a salt-diet which could have contributed to cardiac hypertrophy in 
Dahl hypertensive rats. 
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A high-salt diet has also been shown to increase renal growth in Dahl salt-sensitive and 
salt-resistant rats, although the rate of growth differs between strains (McCormick et al. , 
1989). It has been reported that 4% salt-diet causes renal hypertrophy associated with 
glomerulosclerosis in Dahl SSH rats (Takizawa et al., 1997). The present evidence 
suggests that the SSH rats undergo significant hypertrophy of the kidneys which might be 
due to high-salt diet and hypertension in these animals. 
4. 2.1. Effects of cirazoline in mesenteric bed in vivo 
It was of further interest to investigate if there were any functional changes associated 
I 
with the hemodynamic alterations that had occurred in Dahl salt-sensitive rats on a high-
salt diet. Functional responses to various agonists are believed to be altered in blood 
vessels from Dahl SSH rats (for review see Rapp, 1982). LUscher eta!. (1987) have 
demonstrated that in Dahl SSH rats, contractions in response to noradrenaline in aortic 
rings are increased while relaxation in response to acetylcholine is depressed. It should 
be noted that in a blood vessel, a given response to an agonist might be quite different in 
vivo than in vitro. 
4.2.1.1. Cirazoline effect on blood pressure: In the present study a selective a 1-
adrenoceptor agonist, cirazoline, was infused in anesthetized animals. While cirazoline-
mediated pressor action in Dahl SSH rats was different from SRN rats the slope of the 
cirazoline dose-response curves was not significantly different. In this study, the slope of 
cirazoline dose-response curve can be defined as reactivity ofthe blood vessel. This 
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indicates that cirazoline did not produce a greater contractile response; only the initial 
starting point was different. Several investigators have also suggested that the 
vasoconstrictor response to an agonist (noradrenaline, serotonin) is not different in blood 
vessels (caudal artery, thoracic aorta, tail artery, portal vein, perfused mesenteric bed) 
from Dahl SSH compared to SRN rats on a high-salt diet (Abel et al., 1981; Laher and 
Triggle, 1984; Kong et al. , 1995). 
4.2.1.2. Cirazoline effect on vascular conductance: The cirazoline dose-response curve 
for vascular conductance was found to be shallower in Dahl SSH when compared to SRN 
I 
rats. This may be a reflection of the difference in the initial state of the blood vessel 
diameter and/or be related to alteration in the architecture of the vasculature in Dahl SSH 
when compared to SRN rats. 
4.2.1.3. Cirazoline effect on heart rate: Abnormalities in the baroreflex control of heart 
rate have been identified in experimental (Gordon eta!., 1981) and human hypertension 
(Eckberg, 1979). Slope values were calculated for the regression lines relating the 
increase in blood pressure from baseline versus decrease in heart rate from baseline value 
at various doses of cirazoline. The slopes were found not to be different between Dahl · 
SRN and SSH rats (). In contrast, Gordon et al. (1981) have reported significant 
difference in slope values from conscious Dahl SRN (1.84 ± 0.12 msec mmHg-1) and 
SSH rats (1.11 ± 0.06 msec mmHg- 1). They have suggested impaired baroreflex function 
in hypertensive Dahl salt-sensitive rats on high-salt diet (Gordon et al., 1981). In this 
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study the animals were anesthetized and the anesthetic might have blunted the baroreflex 
control in both the strains. 
4. 2. 2. Effect of cirazoline in isolated mesenteric bed perfused with normal Krebs 
Cirazoline-mediated vasoconstrictor responses were further investigated in isolated 
mesenteric blood vessels. In vitro studies have shown no difference (Abel et al., 1981 ; 
Laher and Triggle, 1984) or an increase (Luscher et a!., 1987; Nishida et a!., 1998) in 
response to vasoconstrictors in blood vessels from Dahl SSH compared to SRN rats. In 
the current investigation, the basal perfusion pressure in the isolated mesenteric bed was 
found not to be different between the Dahl SRN and SSH rats. Indeed, the 
vasoconstrictor responses to the a 1-adrenoceptor agonist, cirazoline, were found not to 
differ in either reactivity or magnitude in the perfused mesenteric bed of Dahl SSH when 
compared to SRN rats in our present study. Laher and Triggle (1984) and Kong et al. 
(1995) had also indicated that there were no alterations in the response to a number of 
vasoconstrictors in the same tissue from Dahl SRN and SSH rats on a high salt diet. In 
fact, it was inferred that the sustained hypertension in Dahl rats had a negative effect on 
the contractility of the mesenteric arterial system (Kong et al. , 1995). Cirazoline-induced 
vasoconstriction is mediated via the activation of a 1A-adrenoceptor subtype in mesenteric 
blood vessels (Rorie et al. , 1995; Williams and Clarke, 1995). Furthermore, radio ligand 
binding experiments showed no differences in overall a 1-adrenoceptor population in 
mesenteric blood vessels in Dahl SRN and SSH rats on a 7% salt diet for 5 days or 3 
weeks (Caveney et al., 1997). In the present investigation a lack of increased sensitivity 
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and an altered magnitude in response to cirazoline may be due to receptor desensitization 
and/or morphological changes in blood vessel of Dahl SSH when compared to SRN rats. 
4.3.1 Effect ofL-NAME on vascular effects ofcirazoline in mesenteric bed in vivo 
It was of further interest to investigate ifL-NAME had a different response in blood 
vessels from Dahl SRN and SSH rats. It is recognized that the basal release of NO in 
blood vessels is decreas.ed in hypertension (for review see Marin and Rodriguez-
Martinez, 1997). Previous reports from our laboratory had indicated that while the 
presence of L-NAME did not have any impact on cirazoline-evoked vasoconstriction in 
isolated aorta (Tabrizchi and Duggan, 2000) and pulmonary artery (Bieger et al., 12004) 
from Dahl SSH rats, it substantially accentuated cirazoline-evoked contractions in blood 
vessels from Dahl SRN rats. As demonstrated in the present experiment, the basal release 
ofNO makes a significant contribution to the maintenance of vascular tone in vivo in 
Dahl SRN rats on a high salt diet. Administration ofL-NAME significantly increased the 
basal blood pressure (1 0 ± 2%; mean ± SEM), decreased mesenteric blood flow (18 ± 
4%; mean± SEM), and mesenteric vascular conductance (25 ± 4%; mean± SEM) in 
SRN but not in SSH rats. This clearly suggests that the blood vessels in SRN rats are in a 
constant state of vasodilation due to basal release of NO. Although in the present study 
we do not find any difference in plasma nitrite/nitrate concentration in Dahl SRN and 
SSH rats, perhaps indicating that the produced NO is compartmentalized. Interestingly, 
in Dahl SRN rats, the treatment with L-NAME blunted cirazoline-induced 
vasoconstriction. This simply implies that in absence ofNO, an already constricted 
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vessel cannot be substantially further constricted by the stimulation of a,-adrenoceptors. 
The inhibition of NO synthase activity in the majority of cases will result in the 
potentiation of vasoconstriction in a blood vessel in vitro subsequent to stimulation of 
post-junctional a-adrenoceptors (Tabrizchi and Duggan, 2000, Bieger et al., 2004). 
However, the behavior of blood vessels towards the NO synthase inhibition can be quite 
variable in vivo. The basis of the difference in the latter case could be related to 
pharmacokinetic andlor·pharmacodynamic aspects of the drugs as well as regional 
differences, and/or due to other compensatory mechanisms that may play a role in 
anesthetized animals. 
4. 3. 2. Effect of L-NAME on cirazoline-induced vasoconstriction in isolated mesenteric 
bed perfused with normal Krebs 
The inhibition of NO synthase in vivo did not result in potentiation of cirazoline-induced 
vasoconstriction in blood vessels from Dahl SRN rats. Hence the effect of L-NAME was 
further examined in the isolated mesenteric bed. In this study, when isolated mesenteric 
blood vessels were perfused with L-NAME there was no change in basal perfusion 
pressure in Dahl SRN and SSH rats. In contrast, perfusion with L-NAME significantly 
increased a ,-adrenoceptor-mediated vasoconstriction in Dahl SRN but not in SSH rats 
suggesting an impaired synthesis ofNO via NO synthase pathway in salt hypertension. 
This clearly corroborates the observation made in the whole animal that, in SSH rats, 
there is a reduction in NO production. Indeed, it has also been demonstrated that the 
basal levels of cGMP are significantly lower in blood vessels of Dahl SSH when 
compared to SRN rats (Tabrizchi and Duggan, 2000; Bieger et al., 2004). 
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The endothelial cell dysfunction observed in Dahl SSH rats cannot be explained by strain 
differences. There are a number of studies that have reported that placing Dahl salt-
sensitive rats on a low-salt diet (0.1-0.45% NaCl) will not result in the development of 
hypertension in this strain. In these Dahl salt-sensitive normotensive rats, endothelial cell 
function is normal and NO/NO synthase pathway behaves in the similar manner as the 
Dahl salt-resistant normotensive rats on either high or low-salt diets (Raij et al., 1988; 
Boegehold, 1992; Nishida et al., 1998). Furthermore, responses to vasoconstrictbrs and 
vasodilators are not altered in Dahl salt-sensitive rats when compared to Dahlsalt-
resistant rats fed a low-salt diet (Abel et al., 1981; Luscher et al., 1987). 
4. 4.1. Effect of niflumic acid on vascular effects of cirazoline in mesenteric bed in vivo 
The effect of Cl-, particularly Ca2+ -dependent Cl channels in mesenteric bed in Dahl SRN 
and SSH rats were investigated. It is known that among the various Cl channel 
antagonists, niflumic acid appears to be the most potent and selective inhibitor of Ca2+-
dependent Cl channels (for review see Large and Wang, 1996). Evidence in the literature 
appears to indicate that niflumic acid is capable of selectively inhibiting Ca2+ -dependent 
Cl channels by blocking the open state of Cl channels (Hogg et al., 1994 ). In addition, 
niflumic acid has been found to produce a concentration-dependent and reversible 
inhibition of noradrenaline-evoked contractions in the rat aorta (Criddle et al., 1996). As 
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well, a comparative study of putative Cl channel antagonists (niflumic acid, 
indanyloxyacetic acid 94 and diphenylamine-2-carboxylic acid) revealed that niflumic 
acid was the most effective in attenuating a 1-adrenoceptor-mediated changes in blood 
flow and vascular conductance in the mesenteric vascular bed in vivo (Parai and 
Tabrizchi, 2002). Collectively the current evidence would appear to support the idea that 
niflumic acid is capable of inhibiting receptor-mediated contraction in blood vessels by 
affecting Ca2+ -dependent Cl channels. 
In this study, niflumic acid did not have any effect on the pressor responses of cirazoline. 
I 
This is consistent with our previous findings in hypertensive and normotensive animals 
(He and Tabrizchi, 1997; Parai and Tabrizchi, 2002). However, it was reported that 
treatment of animals with niflumic acid (the same dose as the present investigation) 
significantly attenuated the constrictor actions of cirazoline on mesenteric blood flow and 
mesenteric vascular conductance in vivo (Parai and Tabrizchi, 2002). In the present 
investigation, it is apparent that niflumic acid inhibited the a 1-adrenoceptor-mediated 
decrease in mesenteric blood flow and mesenteric vascular conductance substantially 
more in Dahl SRN than in Dahl SSH rats. This can be taken to suggest that differences 
exist between blood vessel behaviors in SRN versus SSH rats with respect to the receptor-
mediated signal transduction process. These differences are associated with niflumic 
acid-sensitive processes during a 1-adrenoceptor mediated vasoconstriction. Thus, based 
on current findings, it is possible that alteration to Cl charmel activity is, in part, 
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responsible for differences in a 1-adrenoceptor mediated vasoconstriction in salt-induced 
hypertension. 
4. 4. 2. Effect of nijlumic acid on cirazoline-induced vasoconstriction in isolated 
mesenteric bed perfused with normal Krebs 
The inhibitory effect of niflumic acid was further examined in isolated mesenteric blood 
vessels. Niflumic acid has been found to produce a concentration-dependent and 
reversible inhibition of noradrenaline-evoked (Criddle et al., 1997), as well as, a 1-
adrenoceptor-mediated (He and Tabrizchi, 1997) vasoconstriction in isolated rat 
1 
mesenteric blood vessels. A further investigation of the effects of niflumic acid in 
isolated mesenteric bed revealed that it was able to inhibit a 1-adrenoceptor-mediated 
vasoconstriction substantially more in Dahl SRN than in SSH rats. The latter evidence 
clearly supported the findings in vivo which indicated that niflumic acid had a greater 
inhibitory action on cirazoline-mediated effects in SRN rats. Taken together, this 
reemphasizes the fact that differences exist between blood vessel behavior in SRN versus 
SSH rats with respect to Ca2+ -dependent Cl channels as evidenced by the inhibitory 
actions of niflumic acid on mesenteric blood vessels both in vivo and in vitro. 
In the present study, however, niflumic acid seems to produce a more intense inhibitory 
effect in vitro compared to in vivo in both Dahl SRN and SSH rats. This may be 
attributed to pharmacokinetic and/or pharmacodynamic properties of niflumic acid and/or 
other compensatory mechanisms that may play a role in anesthetized animals. 
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4. 5. Effect of L-NAME and niflumic acid on vascular effects of cirazoline in mesenteric 
bed in vivo 
The observation that niflumic acid had a greater inhibitory response to cirazoline-
mediated effects in vivo and in vitro in Dahl SSH rats raised the question whether this 
difference in behavior is due to endothelial dysfunction in Dahl SSH rats. To elucidate 
this point both L-NAME and niflumic acid were used together in vivo. A report by Lamb 
and Barna ( 1998b) has suggested that the endothelium may regulate vascular tone via an 
effect on vascular smooth muscle Cl channels, although there was no electrophysiological 
I 
evidence presented in that particular study. In the latter study, noradrenaline-induced 
contractions of rat aorta from normotensive rats were potentiated in low Cl- buffer 
depending on the presence of endothelial NO (Lamb and Barna, 1998b ). In addition, a 
dichotomous effect of Cl- removal on cirazoline-evoked contractions in blood vessels 
from Dahl SSH versus SRN rats was reported (Tabrizchi and Duggan, 2000). This study 
demonstrated that while Cl- replacement with propionate ions augmented cirazoline-
evoked contractions in blood vessels of Dahl SRN rats, it depressed the contraction in 
blood vessels of Dahl SSH rats, suggesting the role that Cl- plays in a 1-adrenoceptor-
mediated excitation-contraction-coupling processes of blood vessel is modified in salt-
induced hypertension (Tabrizchi and Duggan, 2000). In the present study, the differences 
in the effects of niflumic acid on cirazoline-mediated vasoconstriction in the mesenteric 
bed in Dahl SRN versus SSH rats were abolished by pretreatment of animals with L-
.... 
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NAME. This appears to suggest that the tonic release of NO has a significant effect on 
niflumic acid-sensitive pathways. 
4.6. Effect of removal of extracellular cr in mesenteric bed 
Since it was not possible to remove cr in vivo, the intestine was taken and investigated 
for the effect of Cl- -free medium (replaced by propionate) in isolated mesenteric blood 
vessels. This study provides evidence of an integral role for Cl- in electromechanical 
function of mesenteric blood vessels in Dahl rats. Removal of Cl- from the perfusion 
media resulted in a transient vasoconstriction in the mesenteric bed of both in the Dahl 
SRN and SSH rats. The vasoconstrictor response was significantly higher in Dahl SSH 
compared to SRN rat~. These phenomena were also observed in a similar preparation in 
2K1C hypertensive and sham normotensive rats (He and Tabrizchi, 1997). It has also 
been suggested that removal of Cl- from the extracellular fluid results in a transient 
membrane depolarization in smooth muscle cells (Aickin and Brading, 1982; Aickin and 
Vermlie, 1983). The observed transient vasoconstriction may have occurred as a 
consequence of sudden shift in cr equilibrium due to exposure of the preparation to Cl--
free medium. Cl- -free medium would be expected to cause efflux ofCr from the 
cytoplasm resulting in depolarization, opening of Ca channels, and subsequent 
contraction (for review see Large and Wang, 1996). Overall, Cl- appears to play a role in 
electromechanical response in vascular smooth muscle (for review see Chipperfield and 
Harper, 2000). 
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4. 6.1. Effect of cirazoline in isolated mesenteric bed perfused with Cr-.free buffer 
It was of further interest to investigate the effect of cirazoline when cr is removed from 
the perfusion medium. Previous reports from our laboratory have suggested a difference 
in vasoconstrictor response in conduit systemic (high pressure) (Tabrizchi and Duggan, 
2000) and pulmonary blood vessels (low pressure) (Bieger et al., 2004) from Dahl SRN 
and SSH in C1--free buffer. Thus the vasoconstrictor response in mesenteric blood 
vessels was examined in C1--free buffer. It was found that a 1-adrenoceptor mediated 
vasoconstriction in mesenteric blood vessels from Dahl SRN rats was inhibited in Cl--
free buffer, which is expected if Cl- is involved in smooth muscle contraction (for 
reviews see Large and Wang, 1996; Chipperfield and Harper, 2000). The inhibitory 
effect ofCl--free medium was absent in Dahl SSH rats. This may be taken to suggest that 
Cl- plays a greater role in blood vessels from SRN rats. As mentioned previously, Cl-
replacement was found to augment cirazoline-evoked contractions in aorta from Dahl 
SRN rats, whereas it depressed the contractions in SSH rats (Tabrizchi and Duggan, 
2000). In contrast, Cl- removal from pulmonary artery did not alter cirazoline-induced 
vasoconstriction in Dahl SRN rats, but it did attenuate the vasoconstriction elicited by 
cirazoline in SSH rats (Bieger et al. , 2004). Based on the data from our laboratory it 
seems clear that the impact of the removal of Cl- from extracellular space and its 
replacement with propionate ions on excitation-contraction coupling is not uniform 
among various blood vessels in the same species, and that Cl- seems to play a variable 
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role on functional responses of blood vessels, this being dependent of on the type of blood 
vessel involved, as well as, pathology. 
4. 6. 2. Effect of L-NAME on cirazoline-induced vasoconstriction in isolated mesenteric 
bed perfused with cr -free buffer 
The influence ofL-NAME in blood vessels from Dahl SRN rat were further examined in 
Cl--free buffer. It is evident that the removal of cr from extracellular space had no 
effects on the potentiating effect of L-NAME at the lower doses of cirazoline, while the 
responses at the higher doses of the agonist were blocked in Dahl SRN rats. This 
I 
evidence may be taken to suggest that the role that cr may play during the process of 
excitation-contraction coupling is dependent on the concentration of agonist. Such may 
not be the case in every blood vessel. For example, in conduit blood vessels, Cl--free 
. 
medium did not have a biphasic effect on the action ofL-NAME on cirazoline-mediated 
contraction in SRN rats (Tabrizchi and Duggan, 2000). In contrast, in pulmonary artery, 
the potentiating effects of L-NAME of the concentration-response curve to cirazoline 
were abolished in Cl--free medium (Bieger eta!., 2004). The effect ofL-NAME in Cr-
free medium further reinforces the view of divergence of effects of Cl- on the process of 
excitation-contraction coupling in different blood vessels even within the same species. 
4. 6. 3. Effect of niflumic acid on cirazoline-induced vasoconstriction in isolated 
mesenteric bed perfused with cr -free buffer 
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It was of further interest to examine if the inhibitory effect of niflumic acid is altered in 
Cr-free medium. Niflumic acid is capable of attenuating cirazoline-mediated 
vasoconstriction in mesenteric blood vessels by inhibiting Ca2+ -dependent Cl channels. 
There was no additional inhibitory effect of niflumic acid on the actions of cirazoline in 
C1--free medium. This would be expected as Cl- would not be making any contribution 
to the process of excitation-contraction coupling in a cr-free medium, thus niflumic acid 
should not be capable of producing any further inhibitory effect which was the case. 
Although a greater inhibitory response to niflumic acid in Dahl SRN rats compared to 
SSH rats was observed in normal Krebs buffer, this difference in inhibitory effect was 
absent in Cl--free me~ium. Therefore, the in vivo and in vitro findings suggest that 
alterations in cr handling and Ca2+ -dependent Cl channels are, in part, responsible for 
altered responses in blood vessels from Dahl SSH rats. 
4.7. Em measurements 
The absence of increased reactivity to cirazoline in blood vessel from Dahl SSH rats 
directed the study towards assessment of Em of these blood vessels. There is conflicting 
evidence in the literature regarding alterations in the resting membrane potential of 
vascular smooth muscle cells of arteries from Dahl SRN when compared to SSH rats. In 
this study, the resting Em in smooth muscle cells from the superior mesenteric artery was 
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not different in Dahl SRN when compared to SSH rats. Abel et al. (1981) have reported 
no significant difference in resting membrane potential of caudal arteries in Dahl SSH 
(-50.2 ± 1.1 mV) and SRN (-51.4 ± 0.9 mV) rats fed an 8% salt diet. Measurements of 
K+, Na+, and Cl- content by electron-probe X-ray analysis showed no significant 
difference in intracellular K+, Na+, or Cl- for Dahl SRN and SSH rats on either low- or 
high-salt diets (Abel et al., 1981). In contrast, Fujii et al. (1997) have reported that the 
resting Em was more positive in the superior mesenteric arteries of Dahl SSH (-41.4 ± 0.5 
mV) when compared to SRN rats (-47.0 ± 0.7 mV). Wellman et al. (2001) had also 
reported that the membrane potential of cerebral artery myocytes from Dahl SSH rats 
f 
(-36.8 ± 0.8 mV) was depolarized compared with similar cells from SRN animals (-49.7 
± 1.2 m V). In contrast, to these observations, it was previously reported that the resting 
Em of pulmonary artery from Dahl SSH ( -52.1 ± 1.04 m V) rats is more hyperpolarized 
when compared to SRN rats ( -46.4 ± 1.58 m V) (Bieger et al. 2004). This divergence was 
further interpreted to be due to humoral/hormonal factors acting to alter vascular smooth 
muscle membrane properties in the low-pressure bed (pulmonary circulation) since the 
pulmonary artery does not experience high blood pressure in Dahl rats, thus promoting 
hyperpolarization (Bieger et al. 2004). Certainly, the lack of consistency between the 
measured Em in various blood vessels in bahl SSH and SRN rat may also point to the 
different nature of Em in blood vessel in different region of the body. 
Em measurements performed in other types of hypertensive rats also seems to differ 
depending on the strains used. For example, Hermsmeyer (1976) have reported that the 
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resting Em of arterial vascular smooth muscle cells from spontaneously hypertensive rats 
are less negative than those from matched Wistar-Kyoto normotensive rats. In contrast, it 
has been reported that the resting Em was found not different between DOCA-salt 
hypertensive and control rats (Hermsmeyer et al., 1982). However, Bratz et al. (2002) 
have demonstrated that vascular smooth muscle cells from L-NNA-treated hypertensive 
rats are depolarized (-36.8 ± 0.8 mV) compared to control rats (-44.5 ± 1.0 mV). 
Although, apparently, there is no difference in the resting Em in smooth muscle cells from 
Dahl SRN and SSH rats in the present investigation, there might be alteration in 
transmembrane signaling processes related to Em changes. 
4. 7.1. Effect of cirazoline on Em 
The resting Em in vascular smooth muscle cells and the contractile response to cirazoline 
in isolated mesenteric bed was not different between the two strains. Thus further studies 
were carried out to investigate if cirazoline produces a change in Em in these blood 
vessels. The issue of agonist-induced changes in the membrane potential of vascular 
smooth muscle cells remains controversial. Suet al. (1964) have shown in the rabbit 
pulmonary artery that there was no change in Em during contraction by sympathetic nerve 
stimulation and noradrenaline. Experiments performed by Casteels et al. (1977) 
confirmed the previous observations that, in the main pulmonary artery, a mechanical 
response can be elicited without depolarization of the membrane at low concentrations of 
noradrenaline. Large (1984) have also provided further evidence that noradrenaline can 
initiate contraction by a mechanism which is not dependent on a change in membrane 
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potential in rat anococcygeous muscle and pharmacomechanical responses appear to be 
responsible for contraction independent of changes in Em of vascular smooth muscle cells. 
Also 5-hydroxytryptamine did not produce a change in the membrane potential of pig 
coronary artery (Frieden and Beny, 1995). In contrast, others have shown a significant 
change in membrane potential associated with contraction (Haeusler, 1978; Haeusler and 
De Peyer, 1989). They have reported that noradrenaline produced 15-17 m V 
depolarizations in vascular smooth muscle cells from rabbit main pulmonary artery 
(Haeusler, 1978). In rabbit aorta, methoxamine depolarized the smooth muscle cells from 
-54.6 mV to -40 mV (Haeusler and De Peyer, 1989). Mulvany et al. (1982) have also 
I 
shown that noradrenaline stimulation depolarized the smooth muscle cells from a resting 
membrane potential of -59.2 mV to -40 mV (a difference of- 19 mV) in rat mesenteric 
arteries. Interestingly, in the present investigation, addition of cirazoline did not 
. 
depolarize the smooth muscle cells from Dahl SRN and SSH rats. The present 
observation may suggest that the vascular smooth muscle is quiescent in nature and/or the 
pharmacomechanical coupling might be playing a major role in contraction of smooth 
muscle. 
It has been suggested that niflumic acid is capable of inhibiting a 1-adrenoceptor-mediated 
vasoconstriction, most probably by inhibiting the Ca2+ -dependent Cl channels and 
subsequently inhibiting depolarization (for review see Larg·e and Wang, 1996). In the 
present investigation, niflumic acid attenuated cirazoline-mediated vasoconstriction. 
Indeed, while cirazoline does not seem to produce sustained membrane depolarization, 
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one cannot rule out the possibility of a transient depolarization since measurements were 
made after 1 0 min exposure. The latter could be due to the activation of Ca2+ -dependent 
Cl channels which is blocked by niflumic acid. This could explain the inhibitory action 
of the latter chemical in cirazoline-elicited vasoconstriction in our present study. 
4. 7. 2. Effect of Cr -free buffer on Em 
The replacement of extracellular Cl- with propionate ions in isolated mesenteric bed 
caused inhibition of cirazoline-mediated vasoconstriction, which raised the question if Cl-
removal will have an effect on the Em. Removal of cr from the extracellular space 
should cause an acute redistribution of Cl- across the cell membrane resulting in 
membrane depolarization. Aickin and Vermlie (1983) have reported that complete 
removal of extracell~lar Cl- causes a decline in intracellular cr activity from 51.1 ± 4.0 
mM to an apparent level of 3.3 ± 0.9 mM. The decline in intracellular Cl- concentration 
could be described by a single exponential process with a mean time constant of 6. 7 ± 1.3 
min (Aickin and Vermiie, 1983). Tl)ey have reported that removal ofCr from 
extracellular fluid results in a transient membrane depolarization in guinea-pig vas 
deferens (Aickin and Brading, 1982) and ureter (Aickin and Vermiie, 1983). In rat 
anococcygeous muscle low Cl- depolarized the membrane from -59.3 ± 0.6 mV to -50.7 
± 1.4 mV (replaced by benzenesulphonate) or -53.2 ± 1.8 mV (replaced by isethionate) 
(Large, 1984 ). On the other hand, Davis et al. (1997) have reported that on switching the 
superfusing solution from normal to cr-free buffer, Em hyperpolarized from -63 .0 ± 2.9 
mV to - 69.4 ± 2.5 mV and intracellular cr concentration fell to an apparent level of 4.4 
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mM from 35.0 mM. Recent evidence from our laboratory indicates that replacement of 
cr with propionate ions produces significant hyperpolarization in pulmonary artery of 
Dahl SRN but not in SSH rats (Bieger et al., 2004). In the present investigation, Cl--free 
buffer caused a significant depolarization of the membrane in Dahl SRN (7.5 ± 0.8 mV; 
mean± SEM) and SSH rats ( 10 ± 1.0 m V; mean ± SEM). Based on the time constant for 
decline of intracellular Cl- concentration in guinea-pig ureter (Aickin and Vermiie, 1983), 
more than 90% of the intracellular Cl- was expected to be removed in 30 min in the 
present investigation. A transient vasoconstriction was observed in mesenteric blood 
vessels in Cr-free buffer. Although some of the intracellular Cr might have been 
I 
replaced by propionate, it is perhaps reasonable to assume that a net reduction in negative 
ion inside the cell might have been responsible for the depolarizing effect observed in the 
present investigation .• 
Surprisingly, while there is a depolarization of vascular smooth muscle in C1--free 
medium, cirazoline-evoked vasoconstriction was attenuated in this medium. This 
strongly implies that Cl- are of critical importance in the process of excitation-contraction 
coupling involving the activation of a 1-adrenoceptors irrespective of the differences in 
membrane potential (for review see Chipperfield and Harper, 2000). However, it is also 
evident that the blood vessels from the Dahl SSH rats underwent a significantly larger 
depolarization compared to SRN rats in C1--free buffer. This may in part explain the 
lesser impact of Cl--free medium on cirazoline-evoked vasoconstriction in blood vessels 
of Dahl SSH in comparison to SRN rats. Thus, our observation could be taken to suggest 
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that there is some degree of dissociation but not a complete dissociation between changes 
in the resting membrane potential and vasoconstriction initiated as consequence of the 
stimulation of a 1-adrenoceptors in mesenteric blood vessels. 
4. 7.3. Effect of L-NAME on Em 
The functional studies have clearly indicated that the presence of L-NAME has an effect 
on the blood vessels from Dahl SRN but not in SSH rats. Thus it was investigated if L-
NAME had an effect on the Em in these blood vessels. The functional studies clearly 
suggest an impaired NO production associated with salt hypertension (Luscher et al., 
I 
1987; Tabrizchi and Duggan, 2000; Bieger et al., 2004). Addition ofL-NAME was 
found to cause depolarization in blood vessels ofSRN rats (5.6 ± 0.8 mV; mean± SEM) 
but such an effect was not detected in SSH rats. This depolarization might again explain 
the exaggerated response to cirazoline in the presence of L-NAME in SRN rats. It seems 
plausible to suggest that NO may have a direct or an indirect (i.e., via cGMP) effect on 
the resting membrane potential of mesenteric vascular smooth muscle cells, in Dahl SRN 
but not SSH rats. It has been suggested that NO can directly activate Ca2+ -dependent K 
channels, leading to endothelium-dependent hyperpolarization of vascular smooth muscle 
cells, resulting in vasodilation (Bolotina et al., 1994). Furthermore, NO has also been 
suggested to cause membrane hyperpolarization (i.e., from -39 ± 1 mV to -48 ± 1 mV) 
by opening voltage-gated K channels in pulmonary artery (Yuan et al., 1996). Bratz et al. 
(2002) have demonstrated that addition ofL-NNA caused a significant depolarization in 
vascular smooth muscle cells from normotensive rats, with Em changing from -44.5 ± 1.0 
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mV to -39.0 ± 1.9 mV, but had no effect on smooth muscle cells from L-NNA-treated 
hypertensive rats. Also endothelium removal resulted in depolarization in smooth muscle 
cells from normotensive when compared to L-NNA-treated hypertensive rats (Bratz eta!., 
2002). It was further demonstrated that superfusion with L-arginine hyperpolarized the 
smooth muscle cells in L-NNA-treated hypertensive and normotensive rats (Bratz eta!., 
2002). Thus it can be suggested that NO seems to have a hyperpolarizing effect on 
resting membrane potential of smooth muscle cells from Dahl SRN but not SSH rats 
which might be, in part, due to opening ofK channels (Bolotina eta!., 1994; Yuan eta!., 
1996). 
The present study demonstrates that L-NAME produces an effect on the Em in smooth 
muscle cells from Dahl SRN but not SSH rats. As an extension of this, it can be 
suggested that perhaps the basal release ofNO is playing a role in maintaining the resting 
Em in Dahl SRN rats. If NO is playing a role in maintaining the resting Em in Dahl SRN 
but not in SSH rats, this further raises the question of why is the resting Em not different 
between the two strains. This might be explained by the fact that in smooth muscle cells 
of Dahl SRN rats, there is perhaps a change in ionic conductance that contributes in such 
a manner that the resting Em is reset at a level which is similar to Dahl SSH rats. 
Evidence from the Em recordings demonstrates that there is no difference between the 
resting Em in vascular smooth muscle cells from superior mesenteric blood vessels in 
Dahl SRN and SSH rats. Furthermore, addition of cirazoline does not depolarize the 
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smooth muscle cells from Dahl SRN and SSH rats. It is observed that removal of Cl-
results in a larger depolarization of the smooth muscle cells in Dahl SSH than SRN rats. 
While L-NAME treatment depolarizes the smooth muscle cells in Dahl SRN, it has no 
effect in the SSH rats. It is possible that the modified role ofNO on membrane potential 
may have a direct bearing on the differences observed in Cl- handling in blood vessels of 
Dahl SRN versus SSH rats. 
4.8. Morphology 
I 
In addition to exploring functional and electrical properties in mesenteric blood vessels, 
simultaneous assessment of morphology was done in the mesenteric blood vessels from 
Dahl SRN and SSH rats on a high-salt diet. There are studies that have presented 
evidence of vascular hypertrophy in mesenteric blood vessels of Dahl SSH but not Dahl 
SRN rats fed a high-salt diet (Lee and Triggle, 1986; Intengan and Schiffrin, 1998). 
Furthermore, mesenteric blood vessels of Dahl salt-sensitive rats fed a low-salt diet do not 
undergo morphological changes (Lee and Triggle, 1986). In the present study, an 
increase in smooth muscle thickness (i.e., vascular hypertrophy) in primary mesenteric 
arteries from Dahl SSH rats was observed. Furthermore, it has been suggested that these 
morphological changes play a critical role in alteration of blood vessels function 
(McGregor and Smirk, 1968; Intengan and Schiffrin, 2001). In fact, it has been argued 
that alteration in responsiveness observed in blood vessels of Dahl SSH rats is, in part, 
due to changes in vascular morphology (Intengan and Schiffrin, 1998). 
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In the present study, there were significant changes in morphometry of primary 
mesenteric arteries but not veins of Dahl SSH rats. Alteration in architecture of the 
primary mesenteric blood vessels will most likely reflect changes that occur in smaller 
blood vessels (e.g., tertiary) (Lee and Triggle, 1986; Intengan and Schiffrin, 1998). 
However, there is no potentiation in the vasoconstrictor actions of cirazoline in Dahl SSH 
when compared to DahL SRN rats in vivo as well as in vitro. An absence of increased 
reactivity, and/or magnitude in response, in blood vessels from Dahl SSH rats might 
possibly be due to secondary compensatory event that occurred in blood vessels such as 
receptor desensitization. 
Furthermore, we have applied the Laplace's law to our in vitro studies. As an extension 
of Laplace' s law, it has been further proposed that the "media thickness/lumen diameter" 
ratio, of a blood vessel is a good correlate of the ability of the vessel to contract against 
intravascular pressure (for review see Zervoudaki and Toutouzas, 2003). Since the 
isolated mesenteric bed was perfused at a constant flow rate and thus it can be assumed 
that the blood vessels contracted against a constant intravascular pressure. Based on 
morphological examination it was revealed that the media thickness/lumen diameter ratio 
of these blood vessels was not different between the two strains. Therefore, this might 
provide the alternate explanation for the absence of increase in magnitude of response in 
blood vessels from Dahl SSH when compared to SRN rats in the current investigation and 
other studies using the same preparation (Laher and Triggle, 1984; Kong et al. 1995). 
Overall, the evidence from our present investigation seems to support the view that any 
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alteration in the behavior of mesenteric blood vessels to the actions of cirazoline can be 
attributed to changes in signal transduction rather than a difference in architecture of· 
blood vessels. 
4.9. Summary 
To summarize the findi1;1gs from this study, it can be inferred that, although the mean 
arterial blood pressure is higher in Dahl SSH rats, there is certainly lack in sensitivity 
and/or magnitude in the vasoconstrictor responses to a 1-adrenoceptor agonist, cirazoline, 
in mesenteric blood vessels of Dahl SSH when compared to SRN rats. This simil~ity in 
vasoconstrictor response can be attributed to the similar resting Em and similar media 
thickness/lumen diameter ratio in blood vessels in Dahl SRN and SSH rats. The evidence 
also suggest an integral role for cr in electromechanical function of mesenteric blood 
vessels in Dahl rats and this role might be altered in salt hypertensive animals. 
Interestingly, these observations also seem to support the concept of a partial dissociation 
between electrical activity and mechanical function in vascular smooth muscle cells 
following the stimulation of a 1-adrenoceptors. Of special interest, is the finding that NO 
may regulate electrical activity and mechanical function in mesenteric blood vessels from 
Dahl SRN but not in SSH rats. The dysfunction of the NO system and Cl- channels could 
contribute to the hypertension observed in the SSH model. 
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This study reveals the fact that high salt consumption is responsible for hemodynamic, 
electrical, mechanical, and morphological changes in blood vessels from Dahl SSH rats. 
Similar changes may also occur in salt-sensitive humans on a moderate high-salt diet over 
a period of time. The high blood pressure and morphology of the blood vessels most 
probably would lead to left ventricular hypertrophy and heart failure. Hence, a reduction 
in salt intake in every individual can be suggested as a preventive measure, and in cases 
where this is not helpful~ pharmacological intervention is the other option. 
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4.10. LIMITATIONS 
As with all experiments, there are certain limitations associated with the present study. 
The anesthetic used might have an effect on the measurements of blood pressure, heart 
rate, and mesenteric blood flow. Also since the animals were anesthetized, the altered 
baroreflex mechanisms in Dahl SSH rats were not observed. It would have been 
optimum if cardiac output was measured simultaneously during the drug infusion. In the 
isolated perfused mesenteric blood vessels, the arterioles were absent which are mainly 
responsible for maintaining elevated peripheral vascular resistance. Furthermore, the 
membrane potential of vascular smooth muscle was recorded from the superior 
mesenteric artery. The ideal scenario would be to measure the Em in the smaller 
resistance arteries along with functional changes. Furthermore, the nitrite/nitrate 
measurements were qone in the plasma sample. The NO/NO synthase activity was not 
assessed in the endothelial cells. It would have been optimal if the eNOS expression were 
investigated in the blood vessels from these rats. 
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